Wire-ready dashboard awaiting your first source connection.
| Details | Saved | Published | Title | Source | Tickers |
|---|---|---|---|---|---|
|
2025-11-18 12:56
5mo ago
|
2025-11-18 07:44
5mo ago
|
Medtronic Lifts Outlook as Quarterly Profit, Sales Rise | stocknewsapi |
MDT
|
|
|
Medtronic raised its fiscal-year outlook after logging higher profit and sales in its latest quarter, boosted by robust demand across end markets and healthy procedure volumes.
|
|||||
|
2025-11-18 12:56
5mo ago
|
2025-11-18 07:44
5mo ago
|
Halper Sadeh LLC Encourages RPTX and SEE Shareholders to Contact the Firm to Discuss Their Rights | stocknewsapi |
RPTX
SEE
|
|
|
NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Repare Therapeutics Inc. (NASDAQ: RPTX)’s sale to XenoTherapeutics, Inc. Upon closing of the proposed transaction, it is estimated that each Repare shareholder will receive a cash payment of $1.82 per share, plus one non-transferable contingent value right entitling the holder to receive certain cash payments under certain conditions. If you are a Repare shareholder, click here to learn more about your rights and options. Sealed Air Corporation (NYSE: SEE)’s sale to funds affiliated with CD&R for $42.15 in cash per share. If you are a Sealed Air shareholder, click here to learn more about your rights and options. Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected]. Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Halper Sadeh LLC Daniel Sadeh, Esq. Zachary Halper, Esq. One World Trade Center 85th Floor New York, NY 10007 (212) 763-0060 [email protected] [email protected] https://www.halpersadeh.com |
|||||
|
2025-11-18 12:56
5mo ago
|
2025-11-18 07:45
5mo ago
|
Fujifilm to Unveil Synapse One, a Comprehensive Enterprise Imaging and Informatics Solution Tailored to Meet the Demands of Outpatient Imaging Centers, at RSNA 2025 | stocknewsapi |
FUJIY
|
|
|
LEXINGTON, Mass.--(BUSINESS WIRE)--FUJIFILM Healthcare Americas Corporation, a leading provider of enterprise imaging and informatics solutions, today announced the launch of Synapse One, a comprehensive, tailor-made workflow solution designed for unique outpatient imaging needs, in North America*. This all-inclusive enterprise imaging solution enables providers to address everything from patient engagement portal, self-scheduling of exams, RIS (Radiology Information System), advanced schedulin.
|
|||||
|
2025-11-18 12:56
5mo ago
|
2025-11-18 07:54
5mo ago
|
Toast: Clover's Stumbles Show Toast's Widening Moat | stocknewsapi |
TOST
|
|
|
Analyst’s Disclosure:I/we have a beneficial long position in the shares of TOST either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body. |
|||||
|
2025-11-18 12:55
5mo ago
|
2025-11-18 07:45
5mo ago
|
Greene Concepts Strengthens National Commitment to Preserving America's Water Sources | stocknewsapi |
INKW
|
|
|
MARION, NC / ACCESS Newswire / November 18, 2025 / Greene Concepts Inc. (OTCID:INKW), owner and operator of a 60,000-square-foot bottling and beverage facility in Marion, North Carolina, announces its dedication to protecting and sustaining America's natural water systems, beginning with its pristine Blue Ridge Mountain aquifer source in Marion, North Carolina. Building on its legacy detailed in Greene Concepts' earlier Accesswire feature, the Company is advancing aquifer conservation initiatives, community partnerships, and water restoration programs aimed at addressing nationwide water scarcity.
|
|||||
|
2025-11-18 12:55
5mo ago
|
2025-11-18 07:45
5mo ago
|
Kikoff Integrates Optimal Path™ Interactive Score Planner from Equifax | stocknewsapi |
EFX
|
|
|
Kikoff Logo
EFX logo Kikoff's One Million-Plus Members will be Equipped to Achieve their Personalized Credit Score Goals and Advance their Financial Health , /PRNewswire/ -- Equifax® (NYSE: EFX) and Kikoff, a personal finance platform that expands access to credit and financial services, today announced that Optimal Path™, the interactive score planner introduced by Equifax earlier this year, will be integrated into the Kikoff platform and rolled out to Kikoff's community of over one million customers. Leveraging the power of The Equifax Cloud™ and patented EFX.AI capabilities, Optimal Path will integrate with each Kikoff member's current Equifax credit profile, to deliver personalized, actionable credit score plans that include specific tasks members can execute over time to help reach their target VantageScore® 3.0 score. "Equifax understands that every consumer's financial situation is unique, and Optimal Path was created in direct response to that," said Felipe Castillo, Chief Product Officer for U.S. Information Solutions at Equifax. "Our Purpose is to help people live their financial best, and we are always striving to create solutions that ultimately empower consumer financial well-being. Kikoff saw the value that Optimal Path could bring to its members, turning individual credit data into clear, actionable guidance, no matter where they are on their financial journey." Kikoff is an AI-powered personal finance platform on a mission to make financial security possible for everyone, no matter where they're starting from. Through its suite of radically affordable and effective tools, Kikoff helps millions of members build credit, reduce costs, and take meaningful control of their financial futures. Optimal Path will enable Kikoff members with the ability to set their credit score goal and identify specific action steps necessary to meet that goal. Recommendations evolve as consumers take action, and members can visualize how the steps they've taken have helped them get closer to their goal. Recommendations are informed not just by the current credit file, but by EFX.AI-driven insights from similar consumers who achieved comparable score objectives. "Kikoff and Equifax both strive to empower individuals along their financial journey and the integration of Optimal Path into our platform is a testament to that," said Cynthia Chen, Founder and CEO of Kikoff. "Optimal Path offers deeply personalized plans that encourage more engagement and financial improvement vs. generic credit-building tools. No matter what a member's current financial situation is, Optimal Path is a true differentiator that can help our members make smarter financial decisions that will enable them to progress faster, advancing their overall financial health." Optimal Path will be rolled out in phases to Kikoff members of all tiers, delivering: Personalized Goal Setting: Kikoff members can set their desired credit score goal as well as a timeframe of three months to one year to reach that goal. Understanding that plans change, goals and timeframes can be easily adjusted by the user. AI-Powered, Specific Recommendations: Advanced AI analytics are used to analyze each user's credit profile and recommend specific tasks – such as reducing past due amounts or lowering credit utilization – the person can perform each month to help achieve personal goals. Estimated Score Impact: Each task presented shows the potential positive impact on the user's VantageScore 3.0 credit score. The potential positive impact is estimated based on the user completing all tasks relating to the same credit factor. Weekly Updates: Optimal Path provides weekly progress updates on the user's current VantageScore 3.0 credit score and performance metrics. New tasks are generated monthly, ensuring the plan stays aligned with the user's goals. Updates continue until the plan reaches the end date set by the consumer. Kikoff has been an Equifax customer since 2019, presenting weekly Equifax credit reports, which includes each individual's VantageScore 3.0 credit score, to their members. The integration of Optimal Path from Equifax into the Kikoff platform represents an expansion of the relationship between the organizations. This integration is part of Kikoff's broader mission to empower financial security through radically affordable, effective solutions. Learn more about how Optimal Path helps consumers meet their credit score goals. ABOUT EQUIFAX INC. At Equifax (NYSE: EFX), we believe knowledge drives progress. As a global data, analytics, and technology company, we play an essential role in the global economy by helping financial institutions, companies, employers, and government agencies make critical decisions with greater confidence. Our unique blend of differentiated data, analytics, and cloud technology drives insights to power decisions to move people forward. Headquartered in Atlanta and supported by nearly 15,000 employees worldwide, Equifax operates or has investments in 24 countries in North America, Central and South America, Europe, and the Asia Pacific region. For more information, visit Equifax.com. ABOUT KIKOFF Kikoff is a personal finance platform on a mission to make financial security accessible to everyone. Through simple, radically affordable products powered by technology and AI, Kikoff helps people build credit, lower debt, and move toward lasting financial stability. To date, more than one million people have increased their credit scores by over 80 million points. Kikoff's growing suite of products also helps users reduce debt, save money, access liquidity, and unlock greater financial opportunity. Learn more at Kikoff.com or by downloading the Kikoff app. FOR MORE INFORMATION: Alexandra Packey for Equifax [email protected] Kikoff [email protected] SOURCE Equifax Inc. |
|||||
|
2025-11-18 12:55
5mo ago
|
2025-11-18 07:45
5mo ago
|
Lennar Confirms Expiration Date of Exchange Offer | stocknewsapi |
MRP
|
|
|
Expects Registration Statement to be Effective by Expiration Date
, /PRNewswire/ -- Lennar Corporation (NYSE: LEN and LEN.B) ("Lennar") confirmed today that in view of the reopening of the U.S. federal government, Lennar is proceeding as previously announced with the offer to exchange the approximately 20% of the total outstanding shares of Millrose Properties, Inc. (NYSE: MRP) ("Millrose") it owns for outstanding shares of Lennar Class A common stock (the "Exchange Offer"). The Exchange Offer is scheduled to expire at 12:00 midnight, New York City time, on November 21, 2025 (the "Expiration Date"). Lennar anticipates accepting the tendered Lennar Class A common stock in the Exchange Offer, subject to possible proration. Yesterday, on November 17, 2025, Millrose requested acceleration of effectiveness of the registration statement on Form S-4 filed by Millrose with the Securities and Exchange Commission ("SEC") in connection with the Exchange Offer (the "Registration Statement"). We expect the Registration Statement to be declared effective before the Expiration Date. However, the Exchange Offer cannot be completed until the Registration Statement is declared effective. If the SEC does not declare the Registration Statement effective by the Expiration Date, Lennar will have to further extend the Exchange Offer or terminate it without accepting tendered shares. About Lennar Lennar Corporation, founded in 1954, is one of the nation's leading builders of quality homes for all generations. Lennar builds affordable, move-up and active adult homes primarily under the Lennar brand name. Lennar's Financial Services segment provides mortgage financing, title and closing services primarily for buyers of Lennar's homes and, through LMF Commercial, originates mortgage loans secured primarily by commercial real estate properties throughout the United States. Lennar's Multifamily segment is a nationwide developer of high-quality multifamily rental properties. LENX drives Lennar's technology, innovation and strategic investments. Forward-Looking Statements This communication contains certain statements about Lennar and Millrose that are forward-looking statements. Forward-looking statements are based on current expectations and assumptions regarding Lennar's and Millrose's respective businesses, the economy and other future conditions. In addition, the forward-looking statements contained in this communication may include statements about the expected effects on Lennar and Millrose of the Exchange Offer, the anticipated timing and benefits of the Exchange Offer, Lennar's and Millrose's anticipated financial results, and other statements that are not historical facts. Because forward-looking statements relate to the future, by their nature, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and are detailed more fully in Lennar's and Millrose's respective periodic reports filed from time to time with the SEC, the Registration Statement relating to the Exchange Offer and the Prospectus forming a part of it, the Schedule TO and other Exchange Offer documents filed by Lennar or Millrose, as applicable, with the SEC. Such uncertainties, risks and changes in circumstances could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Forward-looking statements included herein are made as of the date hereof, and neither Lennar nor Millrose undertakes any obligation to update publicly such statements to reflect subsequent events or circumstances, except to the extent required by applicable securities laws. Investors should not put undue reliance on forward-looking statements. Additional Information and Where to Find It This communication is for informational purposes only and is not an offer to sell or exchange, a solicitation of an offer to buy or exchange any securities or a recommendation as to whether investors should participate in the Exchange Offer. Millrose has filed with the SEC a Registration Statement on Form S-4 that includes the Prospectus. The Exchange Offer is made solely by the Prospectus. The Prospectus contains important information about the Exchange Offer, Lennar, Millrose and related matters, and Lennar will distribute the Prospectus to holders of Lennar Class A common stock. INVESTORS AND SECURITYHOLDERS ARE URGED TO READ THE PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC BEFORE MAKING ANY INVESTMENT DECISION, BECAUSE THEY CONTAIN IMPORTANT INFORMATION. None of Lennar, Millrose or any of their respective directors or officers or the dealer managers appointed with respect to the Exchange Offer makes any recommendation as to whether you should participate in the Exchange Offer. Lennar has filed with the SEC a Schedule TO, as amended from time to time, which contains important information about the Exchange Offer. Holders of Lennar Class A common stock may obtain copies of the Prospectus, the Registration Statement, the Schedule TO and other related documents, and any other information that Lennar and Millrose file electronically with the SEC free of charge at the SEC's website at http://www.sec.gov. Holders of Lennar Class A common stock will also be able to obtain a copy of the Prospectus by clicking on the appropriate link on www.envisionreports.com/lennarexchange. Lennar has retained Georgeson LLC as the information agent for the Exchange Offer. To obtain copies of the Prospectus and related documents, or for questions about the terms of the Exchange Offer or how to participate, you may contact the information agent at +1 (888) 624-7035 (toll-free for stockholders, banks and brokers) or +1 (218) 209-2908 (all others outside the United States and Canada). Contact: Ian Frazer Investor Relations Lennar Corporation (305) 485-4129 SOURCE Lennar Corporation |
|||||
|
2025-11-18 12:55
5mo ago
|
2025-11-18 07:45
5mo ago
|
Jacobs to Lead Terminal Modernization at Ohio's Busiest Airport | stocknewsapi |
J
|
|
|
Cleveland Hopkins International Airport upgrades to improve critical infrastructure
, /PRNewswire/ -- Jacobs (NYSE: J) has been selected to lead program and construction management services for phase one of a $1.6 billion modernization of Cleveland Hopkins International Airport (CLE). The transformative program, CLEvolution, is designed to reimagine the airport experience for millions of travelers by modernizing aging infrastructure enhancing accessibility and passenger flow at Ohio's most traveled airport. Jacobs Executive Vice President Katus Watson said: "CLEvolution is a powerful statement of Cleveland's ambition to transform and revolutionize the travel experience for residents and visitors. As Engineering News-Record's top-ranked aviation firm, Jacobs brings deep experience to 25 of the busiest U.S. airports. With smarter design, expanded amenities and a seamless flow, we're helping deliver an airport experience that matches the pride and hospitality of the city itself and transforms the passenger journey from curb to gate." The program's first phase will deliver: A redesigned terminal entrance inspired by Lake Erie's waves, expanded curbside drop-off and a spacious check-in lobby A consolidated TSA checkpoint and new international arrivals area A new ground transportation center and upgraded train station Expanded parking with a 6,000-space multi-level garage These improvements will support CLE's continued growth, which surpassed 10 million passengers in 2024, and position the airport as a world-class gateway to the region. City of Cleveland Director of Port Control Bryant L. Francis said: "We're proving our commitment to moving this work forward by aligning with the right partners to bring our vision to life. With the continued support of our airline partners and our shared focus on the future, we're laying the foundation for a more modern, efficient, and passenger-focused Cleveland Hopkins International Airport." Ranked as No. 1 in Aviation by Engineering News-Record, Jacobs is shaping the future of aviation infrastructure around the world on projects such as work across Denver International Airport since its inception; the world's largest Consolidated Rent-A-Car facility at Los Angeles International Airport; and the 10-year Manchester Airport Transformation Program in the U.K. At Jacobs, we're challenging today to reinvent tomorrow – delivering outcomes and solutions for the world's most complex challenges. With approximately $12 billion in annual revenue and a team of almost 45,000, we provide end-to-end services in advanced manufacturing, cities & places, energy, environmental, life sciences, transportation and water. From advisory and consulting, feasibility, planning, design, program and lifecycle management, we're creating a more connected and sustainable world. See how at jacobs.com and connect with us on LinkedIn, Instagram, X and Facebook. Certain statements contained in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that do not directly relate to any historical or current fact. When used herein, words such as "expects," "anticipates," "believes," "seeks," "estimates," "plans," "intends," "future," "will," "would," "could," "can," "may," and similar words are intended to identify forward-looking statements. We base these forward-looking statements on management's current estimates and expectations, as well as currently available competitive, financial and economic data. Forward-looking statements, however, are inherently uncertain. There are a variety of factors that could cause business results to differ materially from our forward-looking statements including, but not limited to, uncertainties as to, the timing of the award of projects and funding and potential changes to the amounts provided for under the Infrastructure Investment and Jobs Act and other legislation and executive orders related to governmental spending, including any directive to federal agencies to reduce federal spending or the size of the federal workforce, and changes in U.S. or foreign tax laws, including the new tax legislation enacted in the U.S. in July 2025, statutes, rules, regulations or ordinances, including the impact of, and changes to tariffs and retaliatory tariffs or trade policies, that may adversely impact our future financial positions or results of operations, as well as general economic conditions, including inflation and the actions taken by monetary authorities in response to inflation, changes in interest rates and foreign currency exchange rates, changes in capital markets, the possibility of a recession or economic downturn, and increased uncertainty and risks, including policy risks and potential civil unrest, relating to the outcome of elections across our key markets and elevated geopolitical tension and conflicts, among others. For a description of these and additional factors that may occur that could cause actual results to differ from our forward-looking statements, see our filings with the U.S. Securities and Exchange Commission. The company is not under any duty to update any of the forward-looking statements after the date of this press release to conform to actual results, except as required by applicable law. For press/media inquiries: [email protected] SOURCE Jacobs |
|||||
|
2025-11-18 12:55
5mo ago
|
2025-11-18 07:45
5mo ago
|
IREN: A 40% Pullback In A $3.4B ARR Future | stocknewsapi |
IREN
|
|
|
Iren Limited (IREN) is a rapidly growing dual data center business with a unique blend of Bitcoin mining and AI/HPC hosting operations. IREN's vertical integration, secured 2.9GW power capacity, and strong financing position it well for future growth, despite recent share price volatility. Valuation suggests significant upside potential if execution matches guidance, with a forward P/S ratio becoming attractive by 2027.
|
|||||
|
2025-11-18 12:55
5mo ago
|
2025-11-18 07:45
5mo ago
|
Vistagen Therapeutics: Intranasal Pherines And A Make-Or-Break 2026 | stocknewsapi |
VTGN
|
|
|
Vistagen Therapeutics' intranasal pherine drugs target nose-to-brain circuits. This taps into neuropsychiatric, women's health, and oncology indications. Their lead asset is Fasedienol, which is in Phase 3 for SAD. Its PALISADE-3 data may enable a possible NDA submission during 2026. The rest of VTGN's pipeline includes Itruvone, PH80, and PH284. However, I believe VTGN's tight runway will force them to prioritize Fasedienol's R&D.
|
|||||
|
2025-11-18 12:55
5mo ago
|
2025-11-18 07:48
5mo ago
|
Rolls-Royce: Bank spies more fuel in the tank | stocknewsapi |
RYCEY
|
|
|
RBC Capital looks a little late to the party with the share price up 83% year-to-date, backed by increased defence budgets and a renewed focus on power generation.
Undeterred, the Canadian banks still believe there's a lot to commend Rolls-Royce Holdings PLC (LSE:RR.) and its investment credentials. In an initiation, the bank plants an outperform rating on the shares with a 1,275p price target. The argument is simple enough: the hard work of the turnaround is largely behind Rolls and the business now has enough operating and financial momentum to justify a fresh look. RBC’s analysts describe the past decade of engine durability problems, thin cashflow and a bruising pandemic before noting the shift since 2023, when Tufan Erginbilgic became chief executive. Operating performance has stabilised, cash generation has risen fivefold between 2022 and 2024 and Rolls has built a habit of beating and raising expectations. The bank still expects that pattern to continue, although it concedes the upside is now less dramatic because consensus forecasts already run ahead of management’s 2028 targets. The heart of the pitch is widebody engines. Narrowbody jets may dominate headlines, but RBC argues the gap in long-term growth between the two markets is small. Its own cashflow model values Rolls’s existing widebody portfolio, including engines such as the Trent XWB, Trent 1000 and Trent 7000, at £68 billion net present value, or roughly 70% of the current market capitalisation. Widebody engines form a duopoly with GE, and Rolls is sole supplier on three of its four major programmes. That leaves the business in what the bank calls a cash harvesting phase, with little need for heavy investment until a new widebody platform emerges in the 2040s. The rest of the group receives similar attention. Power Systems, which supplies engines and generators for datacentres, military vehicles and marine uses, is expected to grow at about 10% a year. Defence and business jets add steadier support. None of this includes potential upside from the Ultrafan, Rolls’s next-generation engine, or from its Small Modular Reactor business, which together could add about 400p of value. For now, though, RBC’s view rests on the present rather than the distant future. It sees a business that has found its footing, generates cash and holds solid positions in markets that should grow reliably. |
|||||
|
2025-11-18 12:55
5mo ago
|
2025-11-18 07:48
5mo ago
|
T1 Energy Inc. (TE) Q3 2025 Earnings Call Transcript | stocknewsapi |
TE
|
|
|
Q3: 2025-11-14 Earnings SummaryEPS of -$0.35 misses by $0.20
| Revenue of $210.52M beats by $9.72M T1 Energy Inc. (TE) Q3 2025 Earnings Call November 14, 2025 8:00 AM EST Company Participants Jeffrey Spittel - Executive VP of Investor Relations & Corporate Development Daniel Barcelo - CEO & Chairman Otto Erster Bergesen Evan Calio - Chief Financial Officer Conference Call Participants Philip Shen - ROTH Capital Partners, LLC, Research Division Gregory Lewis - BTIG, LLC, Research Division Sean Milligan - Needham & Company, LLC, Research Division Presentation Operator Good day, and thank you for standing by. Welcome to the T1 Energy Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Jeffrey Spittel, Executive Vice President, Investor Relations and Corporate Development. Please go ahead. Jeffrey Spittel Executive VP of Investor Relations & Corporate Development Good morning, and welcome to T1 Energy's Third Quarter 2025 Earnings Conference Call. With me today on the call are Dan Barcelo, our Chief Executive Officer and Chairman of the Board; Evan Calio, our Chief Financial Officer; Jaime Gualy, our Chief Operating Officer; and Otto Erster Bergesen, our SVP of Project Development. During today's call, management may make forward-looking statements about our business. These forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from expectations. Most of these factors are outside T1's control and are difficult to predict. Additional information about risk factors that could materially affect our business is available in our annual report on Form 10-K filed with the Securities and Exchange Commission and our other filings made with the SEC, all of which are available on the Investor Relations section of our website. With that, I'll turn the call over to Dan. Daniel Barcelo CEO & Chairman Thanks, Jeff, and welcome, everyone, to our third quarter earnings call. Let's turn to Recommended For You |
|||||
|
2025-11-18 12:55
5mo ago
|
2025-11-18 07:50
5mo ago
|
Fortis: A New Capital Plan Extends Decades Of Dividend Growth | stocknewsapi |
FTS
|
|
|
Fortis Inc. (FTS:CA) unveils a $28.8B, 5-year capital plan targeting 7% annualized rate base growth and continued low-risk project execution. FTS maintains its 52-year dividend growth streak, announcing a 4% increase and targeting 4-6% annual dividend growth through 2030. Recent results highlight stable earnings, strong U.S. operations, and a resilient regulatory profile, supporting Fortis' premium valuation among peers.
|
|||||
|
2025-11-18 12:55
5mo ago
|
2025-11-18 07:50
5mo ago
|
Less Paperwork, More Connected Care: Humana and Epic Advance Data Sharing | stocknewsapi |
HUM
|
|
|
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana and Epic advance data sharing through digital innovations that align with federal interoperability priorities and improve patient experience.
|
|||||
|
2025-11-18 12:55
5mo ago
|
2025-11-18 07:50
5mo ago
|
KBR, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – KBR | stocknewsapi |
KBR
|
|
|
LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The DJS Law Group reminds investors of a class action lawsuit against KBR, Inc. (“KBR” or “the Company”) (NYSE: KBR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of KBR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: May 6, 2025 to June 19, 2025 DEADLINE: November 18, 2025 CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. KBR was aware that the Department of Defense had ongoing concerns about its HomeSafe joint venture, specifically about its ability to fulfill its obligations related to the relocation of armed forces services members and their families. Despite knowing about these concerns, the Company claimed to investors that its performance would continue to grow. Based on these facts, KBR’s public statements were false and materially misleading throughout the class period. If you are a shareholder who suffered a loss, contact us to participate. NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. There is no cost or obligation to you to participate in this case. WHY DJS LAW GROUP? DJS Law Group’s primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results. Join the case to recover your losses. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. CONTACT: David J. Schwartz DJS Law Group 274 White Plains Road, Suite 1 Eastchester, NY 10709 Phone: 914-206-9742 Email: [email protected] |
|||||
|
2025-11-18 12:55
5mo ago
|
2025-11-18 07:50
5mo ago
|
RCI Hospitality Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – RICK | stocknewsapi |
RICK
|
|
|
LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The DJS Law Group reminds investors of a class action lawsuit against RCI Hospitality Holdings, Inc. (“RCI” or “the Company”) (NASDAQ: RICK) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of RICK during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: December 15, 2021 to September 16, 2025 DEADLINE: November 20, 2025 CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. RCI allegedly engaged in a complex scheme including bribery of state officials to evade taxes. Based on these facts, RCI’s public statements were false and materially misleading throughout the class period. If you are a shareholder who suffered a loss, contact us to participate. NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. There is no cost or obligation to you to participate in this case. WHY DJS LAW GROUP? DJS Law Group’s primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results. Join the case to recover your losses. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. CONTACT: David J. Schwartz DJS Law Group 274 White Plains Road, Suite 1 Eastchester, NY 10709 Phone: 914-206-9742 Email: [email protected] |
|||||
|
2025-11-18 12:55
5mo ago
|
2025-11-18 07:51
5mo ago
|
Pivotal kidneyintelX.dkd Data Published in Diabetes Care, Considered the Leading Clinical Journal Worldwide in Diabetes | stocknewsapi |
RNLXY
|
|
|
New results and three presentations at ASN Kidney Week underscore kidneyintelX.dkd as a precision-medicine standard for CKD
, /PRNewswire/ -- Renalytix plc (LSE: RENX) (OTCQB: RNLXY), a precision-medicine diagnostics company for kidney health and developer of kidneyintelX.dkd, the only FDA-approved and Medicare-reimbursed prognostic test for early-stage risk assessment in chronic kidney disease (CKD), announced the publication of pivotal new data in Diabetes Care, the top-ranked global diabetes journal of the American Diabetes Association. The published manuscript, "Baseline Risk and Longitudinal Changes in kidneyintelX.dkd and Its Association with Kidney Outcomes in the CANVAS and CREDENCE Trials," was authored by leading nephrology and metabolism experts from the US, Europe, and Australia. The study evaluated 2,954 patients from the landmark CANVAS and CREDENCE trials—representing the full intended-use population for kidneyintelX.dkd. Key Findings Improved CKD risk prediction: kidneyintelX.dkd significantly enhanced risk stratification across all KDIGO guideline categories, delivering more accurate assessment of CKD progression risk and potential kidney failure. Actionable treatment guidance: Among patients classified as moderate or high risk, those treated with frontline SGLT2 inhibitors showed a significant reduction in kidneyintelX.dkd risk levels at one year, with high-risk patients twice as likely to show risk improvement compared with untreated patients. The authors concluded that kidneyintelX.dkd, and its novel kidney biomarkers, enables clinicians to identify patients most likely to benefit from therapy, supporting personalized risk-based care today and offering a powerful tool for future clinical trials. Expert Perspective Associate Professor Brendon Neuen of The George Institute for Global Health, Sydney, an internationally recognizedexpert in cardio-kidney-metabolic health and co-author of the study, commented: "With multiple recent breakthroughs in therapies to reduce kidney function decline, the time for risk-based implementation in CKD has arrived. Incorporating novel biomarkers, as done with kidneyintelX.dkd, holds strong promise to guide risk-based care. These data provide a compelling example of how we can build on well-established clinical parameters to deliver more personalized care and reduce the risk of adverse outcomes." Dr. Neuen serves as Program Lead, Renal & Metabolic at The George Institute and Director of Kidney Trials at Royal North Shore Hospital. kidneyintelX.dkd Spotlighted in Three Presentations at ASN Kidney Week 2025 Renalytix also presented three new abstracts at ASN Kidney Week in Houston (Nov 5–9), highlighting real-world implementation, clinical utility, and performance advantages of kidneyintelX.dkd: 1. PO0330 — Implementation in a Large Integrated Health System Demonstrated a scalable framework for deploying kidneyintelX.dkd to drive sustained population-level adoption and deliver personalized improvements in care management across a major US health network. 2. PO0331 — Decision-Impact Study in Community Practice 87% of patients reported better understanding of their kidney risk. 98% said the test improved their understanding of kidney health and its importance. 86% of physicians said kidneyintelX.dkd directly influenced care decisions. 3. PO0332 — Superior Prediction vs. KFRE kidneyintelX.dkd outperformed the Kidney Failure Risk Equation (KFRE) in predicting kidney function decline or kidney failure in diabetic kidney disease, demonstrating superior discrimination and reliability, especially in early-stage disease. Setting a New Standard in CKD Precision Medicine Across clinical trials, real-world deployment, and head-to-head performance comparisons, kidneyintelX.dkd continues to show consistent, incremental value as a core component of precision medicine in CKD. These results support its role as a transformative tool in integrated care management—ultimately driving significant improvements in patient and health outcomes. About Chronic Kidney Disease: a worldwide public health crisis Chronic Kidney Disease is a worldwide public health crisis impacting 850 million individuals worldwide. According to the National Kidney Foundation, it is estimated to impact more than 35 million adults in the United States and 90% of those do not know they have it, with Medicare spending over $130 billion annually to care for those with kidney disease and kidney failure. About Renalytix Renalytix (LSE: RENX) (OTCQB: RNLXY) is an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes. Renalytix has received FDA approval and Medicare reimbursement for kidneyintelX.dkd which is now offered commercially in the United States. To learn more about Renalytix, visit renalytix.com, and for information about the kidneyintelX.dkd test, visit kidneyintelx.com. For further information, please contact: SOURCE Renalytix plc |
|||||
|
2025-11-18 12:55
5mo ago
|
2025-11-18 07:51
5mo ago
|
Trump, one of McDonald's 'all time most loyal customers,' offers Filet-O-Fish suggestion | stocknewsapi |
MCD
|
|
|
President Donald Trump gave McDonald's leadership a not-so-subtle hint at how the massive chain could improve the iconic Filet-O-Fish.
"I like the fish. I like it. You could do a little bit more tartar sauce, so please," Trump said while delivering remarks at the McDonald's Impact Summit 2025 in Washington, D.C. He added that he hates having to ask for more sauce. In the same speech, Trump joked that he was the first former McDonald's fry cook to become president, referencing his famous 2024 campaign stop. He then took a swipe at his opponent in the 2024 race, then-Vice President Kamala Harris, saying that he was there longer than she was, even though she claimed to have worked at McDonald's. TRUMP TALKS FALLING INFLATION AT MCDONALD’S AND WALMART President Donald Trump gestures at the McDonald's Impact Summit at the Westin Hotel in Washington, D.C., Nov. 17, 2025. (Evelyn Hockstein/Reuters / Reuters) "I’m honored to stand before you as the very first former McDonald’s fry cook ever to become President of the United States," Trump said. "And I actually was there for about 30 minutes, and that was 30 minutes longer than Kamala was there, despite her job at McDonald’s." Trump then thanked the McDonald's employee who informed his campaign that Harris never worked for the Golden Arches. He also expressed his love for McDonald's, calling himself one of the fast-food giant's "all-time most loyal customers." "I’m also one of your all-time most loyal customers," Trump said. "Well, other politicians fly around on campaign planes stocked with expensive catering, when Trump Force One — prior to ascending to Air Force One, which is quite a nice plane also — we served only McDonald's almost every time." MCDONALD’S CEO WARNS RISING BEEF PRICES REMAIN A CHALLENGE AS INFLATION STAYS ‘STICKY’ Republican presidential nominee, then-former U.S. President Donald Trump works behind the counter making french fries during a visit to McDonald's restaurant on Oct. 20, 2024. (Doug Mills-Pool/Getty Images / Getty Images) The president said that during the campaign he got Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. to eat a Big Mac and that "he loved it." Trump joked that the famously health-focused Kennedy "didn't want that publicized." While speaking at the summit, the president addressed the broader issue of affordability, touting his administration's success, while admitting that some products are still more expensive than they should be. "We have a couple of items like coffee, which is a little high. We're going to get that down," Trump said. He also recalled that early in his second term, he was asked about the price of eggs almost immediately after entering office. CELEB CHEF PRAISES TRUMP'S MCDONALD'S SHIFT, SAYS HE 'SHINED A LIGHT' ON 'FORGOTTEN POSITION' OF FOOD INDUSTRY President Donald Trump delivers remarks at the McDonald's Impact Summit at the Westin Hotel in Washington, D.C., Nov. 17, 2025. (Evelyn Hockstein/Reuters) Despite acknowledging the high price of coffee, Trump argued that the economy was rebounding under his leadership. "In the past six months, the price of breakfast items has fallen 14%," Trump said. "Bread prices are down, dairy prices are down, and the price of eggs has declined 86% since March. I want to give a very special thanks to McDonald’s for slashing prices for the most popular items. We’re getting prices down for this country, and there’s no better leader or advocate than McDonald’s." He said that the stock market shows the rebound that his administration worked to achieve, adding that the stock market reached its all-time high 48 times over the course of nine months. Trump also said that the American people are seeing that the country is "doing better." The president asserted that things are only going to improve. "These new heights of prosperity are going to be incredible," he said. "We're looking at affordability. We're going to bring it down for everybody." GET FOX BUSINESS ON THE GO BY CLICKING HERE Trump concluded his remarks by painting McDonald's as a partner in his vision for an improved economy. "So, together we're going to make America richer, stronger, prouder, and happier than ever before. And you people can be very, very proud of the job you've done. You're respected all over the world, and it's an honor to be with McDonald's," he said. Fox News Digital’s Greg Wehner and Stepheny Price contributed to this report. |
|||||
|
2025-11-18 11:56
5mo ago
|
2025-11-18 06:30
5mo ago
|
Perception of Customer Experience at a New Low, Survey from Broadridge Reveals | stocknewsapi |
BR
|
|
|
More than half of North Americans have lost trust in a company that delivers a poor experience or unclear communication
, /PRNewswire/ -- As companies across sectors race to stimulate consumer loyalty and provide differentiation, customer communications and digital experiences are under-appreciated levers in unlocking customer satisfaction, according to the seventh annual CX and Communications Consumer Insights study by Broadridge Financial Solutions Inc. (NYSE: BR). The study, which polled over four-thousand American and Canadian consumers, reveals a new, all-time-high for customer dissatisfaction: 71% of consumers – two times more than those in 2019 – agree that most companies need to improve their customer experience. "Customer communications aren't just touchpoints — they're the heartbeat of the customer experience," said Christoph Stehmann, president of Broadridge Customer Communications. "Today's consumers are demanding clarity, simplicity, and seamless interactions across every channel. Companies that fail to deliver will lose trust and relevance. Those that prioritize clear, timely, and engaging communication will rise above competitors, earn lasting loyalty, and drive measurable business growth. In times of uncertainty, the brands that make life easier for their customers will always win." While the data shows how evolving customer dynamics are reinforcing the previously known gaps in expectations and reality, Broadridge's report helps highlight what's at risk if firms don't prioritize addressing customer experience, insights on a persona-based approach to communications strategy, and consumer perspective on AI in communications. Overall, 59% of respondents have lost trust in a company that delivers a poor experience or unclear communication. The top three functions companies should prioritize to build trust and make a great experience include: Honoring their preferred communication channels (39%) Providing a simple way for them to engage across channels (38%) Simplifying the way they do business with companies (33%) Taking a Persona-based Approach to Communications Strategy The study also identified two key customer personas that businesses should be considering when developing their CX strategy: Engaged Explorers are proactive, curious consumers who actively seek out information and prefer to dig deeper before making decisions. Explorers demand more depth and context and are interested in more custom, personalized content. When it comes to communications, they also prefer emails to be interactive (84%) and simultaneously would like to see bills and statements exist in one place digitally (87%). This group believes companies aren't delivering advanced, interactive experiences – with only 15% believing they receive a quality experience. By contrast, Practical Optimizers are pragmatic consumers who value efficiency and reliability above all else. They prefer straightforward, easy-to-use digital tools and clear communication that helps them act quickly without unnecessary complexity. Nearly half of the group (44%) prioritizes clear and transparent communications as a critical component of their journey. This group has a better perception of the CX they receive, with 41% agreeing that companies deliver on experience. "Businesses are always looking for how to better serve clients. By identifying persona archetypes that cross over between standard demographics such as income and education, we can illuminate what matters most," said Matt Swain, head of communications insights and experience at Broadridge. "While Explorers and Optimizers have distinct priorities and tech adoption preferences, the research shows that companies can serve both personas well if they're prioritizing delivering simple, intuitive, omni-channel communications experiences." AI Adoption Grows, but Consumer Expectations are Rising While AI is still top-of-mind for many firms, for the second year in a row, respondents have not had a favorable opinion of the technology in practice. Only one-third (37%) say it has improved their overall experience, just slightly up from 33% last year. Data shows a stark difference in perception between the two persona groups: Explorers are more open to AI innovation, with 70% saying AI has improved their experience. Only 33% of Optimizers, who expect clear benefits and the reassurance of human support, think AI has improved their customer experience. That said, when it comes to providing data that powers these AI tools, consumers are increasingly comfortable sharing their data with companies to improve their digital experiences, as 62% of consumers are more likely to engage digitally with companies who've set up advanced security measures, and 52% are more likely to share personal data if it results in a better experience. The message from customers is unmistakable: Communications are coming up short. As companies strive for clarity, connection, and trust, they cannot overlook efficiency, cost savings, and scale – and to uncover these friction points, they need to respond directly to the issues customers are being loud and clear about. Paper Isn't dead — It's Evolving, Redefining Engagement Even with digital advances, 55% of consumers still receive paper. That said, nearly half would switch if digital options were more intuitive and secure. The takeaway: "go paperless" works best as an invitation, not a mandate. When customers have choice and control, adoption follows, the average paperless uptake is 45%, with adoption by industry ranging from 32% to 61%. To access the full study, click here. Survey methodology Broadridge commissioned Big Village to conduct this CARAVAN survey. This survey, as part of Broadridge's annual series, was conducted in a fashion consistent with previous years. The survey was taken by 4,018 U.S. and Canadian residents aged 18 and older. The U.S. data was weighted by age, sex, geographic region, race, and education. The Canadian data was weighted by age, sex, and geographic region to have a significant sample of each population. About Broadridge Broadridge Financial Solutions (NYSE: BR) is a global technology leader with trusted expertise and transformative technology, helping clients and the financial services industry operate, innovate, and grow. We power investing, governance, and communications for our clients – driving operational resiliency, elevating business performance, and transforming investor experiences. Our technology and operations platforms process and generate over 7 billion communications annually and underpin the daily average trading of over $15 trillion in equities, fixed income, and other securities globally. A certified Great Place to Work®, Broadridge is part of the S&P 500® Index, employing over 15,000 associates in 21 countries. For more information about us, please visit www.broadridge.com. Media Contacts: Europe [email protected] North America [email protected] Asia-Pacific [email protected] SOURCE Broadridge Financial Solutions, Inc. |
|||||
|
2025-11-18 11:56
5mo ago
|
2025-11-18 06:30
5mo ago
|
Bio-Techne Licenses AI-Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio | stocknewsapi |
TECH
|
|
|
Partnership strengthens Bio-Techne's leadership in AI-enabled protein innovation
NovoBody™ Duo molecules offer multi-specific binding capabilities for advanced research and diagnostics Collaboration aligns with Bio-Techne's strategic growth pillars and megatrends in precision medicine , /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced a licensing agreement with Monod Bio, a Seattle-based biotechnology company spun out from the Nobel Prize-winning David Baker lab at the University of Washington, Institute for Protein Design. The agreement grants Bio-Techne exclusive commercial rights to a specific subset of Monod's NovoBody™ Duo molecules, a new class of AI-designed bispecific binding proteins. "This partnership marks an exciting step forward in how we are using artificial intelligence to advance scientific progress," said Will Geist, President of the Protein Sciences Segment at Bio-Techne. "NovoBody™ Duo molecules extend our portfolio with innovative AI-powered designs and state-of-the-art customization, stability, and performance, enabling customers to target complex biology with greater precision and accelerate the development of better therapies." Alfredo Quijano Rubio, PhD, CSO of Monod Bio commented, "NovoBody™ Duo molecules are compact, tunable, and rapidly adaptable for multi-specific binding applications. Unlike traditional antibodies, they can be engineered quickly and cost-effectively, making them ideal for next-generation research tools and diagnostics." "We are thrilled to partner with Bio-Techne, whose commitment to innovation and scientific excellence aligns perfectly with our mission," said Daniel Silva Manzano, PhD, CEO of Monod Bio. "This collaboration validates our platform and accelerates the integration of Monod's AI-designed proteins into mainstream life sciences." The agreement supports Bio-Techne's strategic growth vectors, supporting the discovery of novel biological insights and the development of advanced therapeutics. It also reinforces the company's position at the forefront of AI-enabled innovation—a key megatrend driving global healthcare transformation. ABOUT BIO-TECHNE: Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated over $1.2 billion in net sales in fiscal 2025 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the company on social media at LinkedIn, X, or YouTube. ABOUT MONOD BIO: Monod Bio is a Seattle-based biotechnology company and a spinout from the David Baker Lab at the University of Washington's Institute for Protein Design. The company uses AI-powered de novo protein design to create novel protein binders and biosensors for research use only (RUO) and in vitro diagnostic (IVD) applications. Monod Bio's proprietary platform enables the generation of novel proteins, including its NovoBody™ binders, to address unmet needs. Through its "Monod Inside" business model, Monod Bio partners with leading RUO and IVD organizations to bring next-generation products to market. For more information, visit http://monod.bio. MEDIA CONTACTS: Corporate Communications [email protected] David Clair, Vice President Investor Relations & Corporate Development [email protected] Julie Rathbun Investor Relations [email protected] SOURCE Bio-Techne Corporation |
|||||
|
2025-11-18 11:56
5mo ago
|
2025-11-18 06:30
5mo ago
|
Kennametal to Attend UBS Global Industrials & Transportation Conference | stocknewsapi |
KMT
|
|
|
Resources
Investor Relations Journalists Agencies Client Login Send a Release News Products Contact , /PRNewswire/ -- Kennametal Inc. (NYSE: KMT) announced today that they will attend the UBS Global Industrials & Transportation Conference in Manalapan, FL. Details of the conference are as follows: When: Tuesday, December 2, 2025 Attendees: Patrick Watson, Vice President and Chief Financial Officer David Bersaglini, Vice President Kennametal Inc., President Metal Cutting Michael Pici, Vice President, Investor Relations About Kennametal With over 85 years as an industrial technology leader, Kennametal Inc. delivers productivity to customers through materials science, tooling and wear-resistant solutions. Customers across aerospace and defense, earthworks, energy, general engineering and transportation turn to Kennametal to help them manufacture with precision and efficiency. Every day approximately 8,100 employees are helping customers in nearly 100 countries stay competitive. Kennametal generated nearly $2 billion in revenues in fiscal 2025. Learn more at www.kennametal.com. Follow @Kennametal: Instagram, Facebook, LinkedIn and YouTube. SOURCE Kennametal Inc. Also from this source |
|||||
|
2025-11-18 11:56
5mo ago
|
2025-11-18 06:30
5mo ago
|
ITURAN PRESENTS THIRD QUARTER 2025 RESULTS | stocknewsapi |
ITRN
|
|
|
Record revenue of $92.3 million and added 40,000 net new subscribers in the quarter
, /PRNewswire/ -- Ituran Location and Control Ltd. (NASDAQ: ITRN) today announced its consolidated financial results for the third quarter, ended September 30, 2025. Highlights of the Third Quarter of 2025 Added 40,000 net subscribers in the quarter. Revenue of $92.3 million, an 11% increase year-over-year. Net income increased to $14.6 million, a 7% increase year-over-year. EBITDA totaled $24.6 million, a 6% increase year-over-year. The Board declared a quarterly dividend of $10.0 million, or $0.50 per share. Management Comment Eyal Sheratzky, Co-CEO of Ituran said, "The third quarter marked a strong quarter for Ituran, in particular, we showed strong subscription revenue growth. Ituran's overall subscriber growth is being driven by our long-term efforts and success in bringing customers new value-adding telematics and connected-car products and services, as well as adding additional OEM partners to our growing roster." Continued Mr. Sheratzky, "I am excited that during the quarter, following its success in Brazil, we have launched operations for IturanMOB in the United States. IturanMOB is our unique smart-mobility solution enabling remote vehicle access, real-time telematics and efficient fleet management for shared-mobility and rental-fleet application. We believe this creates an additional long term growth engine for Ituran with a large untapped addressable market alongside our core telematics and subscriber-based businesses." Concluded Mr. Sheratzky, "In celebration of 20 years as a public company and 30 years as a Company, we look forward to opening the Nasdaq market on November 25 and we thank both the Nasdaq as well as our shareholders for their long-term support of our business." Third Quarter 2025 Results Revenues for the quarter were $92.3 million, an increase of 11% compared with $83.5 million in the third quarter of 2024. 73% of revenues were from location-based service subscription fees and 27% were from product revenues. Revenues from subscription fees for the quarter were $67.6 million, an increase of 13% year-over-year. The subscriber base grew to 2,588,000 by the end of September 2025, marking a quarterly increase of 40,000 and a year-over-year increase of 219,000. Product revenues for the quarter were $24.7 million, an increase of 4% year-over-year. Gross profit for the quarter was $46.4 million (50.3% of revenues), a 16% increase compared with $40.2 million (48.1% of revenues) in the third quarter of 2024. Gross margin on subscription revenues was 60.1%, compared to 58.8% last year. Gross margin on product revenues was 23.6%, compared to 21.5% last year. The variance in the product gross margin between quarters reflects changes in the mix of products sold in the quarter. Operating income for the quarter was $19.6 million (21.3% of revenues), a 7% increase compared with $18.4 million (22.0% of revenues) in the third quarter of 2024. EBITDA for the quarter was $24.6 million (26.7% of revenues), a 6% increase compared with $23.3 million (27.9% of revenues) in the third quarter of 2024. Net income for the quarter was $14.6 million (15.9% of revenues), or $0.74 per diluted share, an increase of 7% compared to $13.7 million (16.4% of revenues), or $0.69 per diluted share, in the third quarter of 2024. Cash flow from operations for the quarter was $21.3 million. On the balance sheet, as of September 30, 2025, the Company had net cash, including marketable securities, of $93.1 million, compared with $77.3 million at year-end 2024. Dividend The Board of Directors declared a dividend of $10.0 million for the quarter. The current dividend takes into account the Company's continuing strong profitability, ongoing positive cash flow, and strong balance sheet. Buy Back During the quarter, Ituran purchased $1.5 million in shares under its Buy Back program. There remains approximately $5.2 million available under the buy-back program. Conference Call Information The Company will be hosting a video conference call via the Zoom platform later today, Tuesday, November 18, 2025 at 9am Eastern Time and 4pm Israel time. On the call, management will review and discuss the results and will be available to answer investor questions. To participate in the Zoom call, please register at the following link: https://us06web.zoom.us/webinar/register/WN_FseStmWFR6SpOakhbm71ow https://us06web.zoom.us/webinar/register/WN_v7fBVdwwT-KnDOQ7OfgoBA For those unable to listen to the live call, a replay of the call will be available from the day after the call in the investor relations section of Ituran's website. Certain statements in this press release are "forward-looking statements" within the meaning of the Securities Act of 1933, as amended. These forward-looking statements include, but are not limited to, our plans, objectives, expectations and intentions and other statements contained in this report that are not historical facts as well as statements identified by words such as "expects", "anticipates", "intends", "plans", "believes", "seeks", "estimates" or words of similar meaning. These statements are based on our current beliefs or expectations and are inherently subject to significant uncertainties and changes in circumstances, many of which are beyond our control. Actual results may differ materially from these expectations due to changes in global political, economic, business, competitive, market and regulatory factors, as well as other factors. About Ituran Ituran is a leader in the emerging mobility technology field, providing value-added location-based services, including a full suite of services for the connected-car. Ituran offers Stolen Vehicle Recovery, fleet management as well as mobile asset location, management & control services for vehicles, cargo and personal security for the retail, insurance, financing industries and car manufacturers. Ituran is the largest OEM telematics provider in Latin America. Its products and applications are used by customers in over 20 countries. Ituran is also the founder of the Tel-Aviv based DRIVE startup incubator to promote the development of smart mobility technology. Ituran's subscriber base has been growing significantly since the Company's inception to over 2.5 million subscribers using its location-based services with a market leading position in Israel and Latin America. Established in 1995, Ituran has approximately 2,800 employees worldwide, with offices in Israel, Brazil, Argentina, Mexico, Ecuador, Columbia, India, Canada and the United States. For more information, please visit Ituran's website, at: www.ituran.com Company Contact Udi Mizrahi [email protected] Deputy CEO & VP Finance, Ituran (Israel) +972 3 557 1348 International Investor Relations Ehud Helft [email protected] EK Global Investor Relations (US) +1 212 378 8040 ITURAN LOCATION AND CONTROL LTD. CONDENSED CONSOLIDATED BALANCE SHEETS US dollars September 30, December 31, (In thousands) 2025 2024 (unaudited) Current assets Cash and cash equivalents 93,072 77,357 Investments in marketable securities 2 10 Accounts receivable (net of provision for credit loss) 62,059 47,688 Other current assets 49,396 46,067 Inventories 25,672 23,434 230,201 194,556 Long-term investments and other assets Investments in affiliated companies 494 519 Investments in other companies 1,833 1,491 Other non-current assets 5,290 5,853 Deferred income taxes 14,828 12,273 Funds in respect of employee rights upon retirement 26,495 21,823 48,940 41,959 Property and equipment, net 39,970 33,080 Operating lease right-of-use assets, net 8,323 8,947 Intangible assets, net 8,932 9,011 Goodwill 39,690 39,325 Total assets 376,056 326,878 ITURAN LOCATION AND CONTROL LTD. CONDENSED CONSOLIDATED BALANCE SHEETS (cont.) US dollars September 30, December 31, (In thousands) 2025 2024 (unaudited) Current liabilities Credit from banking institutions - 114 Accounts payable 20,380 18,847 Deferred revenues 26,620 22,857 Other current liabilities 55,398 45,904 102,398 87,722 Long-term liabilities Deferred income taxes 520 418 Liability for employee rights upon retirement 32,754 27,593 Deferred revenues 14,637 12,231 Operating lease liabilities, non-current 4,852 5,562 Other non-current liabilities 2,385 2,095 55,148 47,899 Stockholders' equity 211,997 185,227 Non-controlling interests 6,513 6,030 Total equity 218,510 191,257 Total liabilities and equity 376,056 326,878 ITURAN LOCATION AND CONTROL LTD. CONDENSED CONSOLIDATED STATEMENTS OF INCOME US dollars Nine months period ended September 30, Three months period ended September 30, (in thousands, except earnings per share) 2025 2024 2025 2024 Revenues: Telematics services (unaudited) (unaudited) 193,486 180,943 67,550 59,591 Telematics products 72,040 72,431 24,728 23,888 265,526 253,374 92,278 83,479 Cost of revenues: Telematics services 79,684 75,320 26,950 24,574 Telematics products 54,477 58,550 18,903 18,748 134,161 133,870 45,853 43,322 Gross profit 131,365 119,504 46,425 40,157 Research and development expenses 15,654 13,607 5,734 4,490 Selling and marketing expenses 13,491 11,291 4,857 4,019 General and administrative expenses 45,586 41,571 16,217 13,264 Other expenses (income), net 18 (99) (9) 24 Operating income 56,616 53,134 19,626 18,360 Financing income (expenses), net (1,122) 165 (340) 34 Income before income tax 55,494 53,299 19,286 18,394 Income tax expenses (11,221) (11,234) (3,892) (4,029) Share in losses of affiliated companies, net (31) (301) (13) (179) Net income for the period 44,242 41,764 15,381 14,186 Less: net income attributable to non-controlling interest (1,552) (1,948) (736) (533) Net income attributable to the company 42,690 39,816 14,645 13,653 Basic and diluted earnings per share attributable to company's stockholders 2.15 2.00 0.74 0.69 Basic and diluted weighted average number of shares outstanding 19,892 19,894 19,889 19,894 ITURAN LOCATION AND CONTROL LTD. CONSOLIDATED STATEMENTS OF CASH FLOWS US dollars Nine months period ended September 30, Three months period ended September 30, (in thousands) 2025 2024 2025 2024 (unaudited) (unaudited) Cash flows from operating activities Net income for the period 44,242 41,764 15,381 14,186 Adjustments to reconcile net income to net cash from operating activities: Depreciation and amortization 14,240 15,586 5,010 4,935 Loss in respect of trading marketable securities and other investments 8 85 - 50 Increase in liability for employee rights upon retirement 2,134 2,245 512 565 Share in losses of affiliated companies, net 31 301 13 179 Deferred income taxes (891) (1,340) (504) (104) Capital loss on sale of property and equipment, net 99 14 10 109 Decrease (increase) in accounts receivable (8,458) (4,792) (767) 1,752 Decrease (increase) in other current and non-current assets 6,203 (5,328) 1,403 (957) Decrease (increase) in inventories (911) 2,591 (853) 1,062 Decrease in accounts payable (812) (2,382) (688) (4,198) Increase (decrease) in deferred revenues 2,315 186 961 (186) Increase (decrease) in other current and non-current liabilities 1,028 2,645 865 (158) Net cash provided by operating activities 59,228 51,575 21,343 17,235 Cash flows from investment activities Increase in funds in respect of employee rights upon retirement, net of withdrawals (2,322) (2,337) (1,470) (822) Capital expenditures (17,169) (9,144) (5,295) (2,835) Return from (investments in) affiliated and other companies, net (49) (2) 61 (59) Repayment of (Investment in) long-term deposit 35 (81) 58 (104) Proceeds from sale of property and equipment 564 389 110 96 Net cash used in investment activities (18,941) (11,175) (6,536) (3,724) Cash flows from financing activities Short term credit from banking institutions (114) (384) - (53) Acquisition of company shares (1,475) - (1,475) - Dividend paid (27,652) (20,291) (9,947) (7,758) Dividend paid to non-controlling interests (1,677) (3,261) - (1,631) Net cash used in financing activities (30,918) (23,936) (11,442) (9,442) Effect of exchange rate changes on cash and cash equivalents 6,346 (2,433) 952 186 Net change in cash and cash equivalents 15,715 14,031 4,337 4,255 Balance of cash and cash equivalents at beginning of period 77,357 53,434 88,735 63,210 Balance of cash and cash equivalents at end of period 93,072 67,465 93,072 67,465 Supplementary information on financing activities not involving cash flows: In August 2025, the Company declared a dividend in an amount of US$10 million. The dividend was paid in October 2025. Logo - https://mma.prnewswire.com/media/1972820/Ituran_logo.jpg SOURCE Ituran Location and Control Ltd. |
|||||
|
2025-11-18 11:56
5mo ago
|
2025-11-18 06:31
5mo ago
|
Emirates to hold Boeing's 'feet to the fire' to deliver on $38 billion deal, president says | stocknewsapi |
BA
|
|
|
Emirates is piling the pressure on Boeing to deliver on a $38 billion order placed this week, the airline's president told CNBC on Tuesday.
Speaking to CNBC at the Dubai Airshow, Emirates President Tim Clark said he had faith Boeing could "restore [its] former glory" — but nonetheless, the airline is doing what it can to ensure the beleaguered aircraft manufacturer holds up its end of the agreement. Emirates announced Monday it has placed an order for 65 Boeing 777-9 planes, worth $38 billion at list prices — taking Emirates' total orderbook with the planemaker to 315 widebody jets. Clark told CNBC the airline was hoping to receive the first of the new Boeing aircraft in the second quarter of 2027. Emirates is Boeing's biggest customer when it comes to wide-body aircraft, but the airline has been struggling with prolonged delays to Boeing's 777X program amid certification and production challenges. Boeing has also struggled to deliver other aircraft, including its 737 jets, after a strike at the firm late last year hit production. "We're kind of holding Boeing's feet to the fire," Clark said, noting that while the aircraft is "sound," Boeing is having to contend with huge certification requirements that come with a new aircraft and slower processes at the Federal Aviation Administration which has been impacted by the U.S. government shutdown. Restoring Boeing's 'former glory'Emirates has been critical of delays to deliveries from Boeing in the past, with Chairman and CEO Sheikh Ahmed bin Saeed Al Maktoum telling CNBC last year that the airline was "not happy really with what's going on." Amid the delays, Emirates has spent billions of dollars retrofitting its older planes to plug capacity gaps. Other airlines have also been impacted by postponements to Boeing deliveries. Earlier this year, budget airline Ryanair cut its passenger traffic goal, citing Boeing delays. Despite Boeing's ongoing challenges, however, Clark told CNBC he expects Boeing can, and will, turn itself around. "I know the Boeing of old, and I know what Boeing could do, and they were really, really a great company," he said. "I see no reason why what has happened in the last decade cannot be fixed, and that Boeing cannot restore itself to its former glory of being an aeronautical engineering designer of excellence." watch now Boeing has also come under intense scrutiny in recent years following a series of fatal crashes involving its aircraft. Earlier this year, a Boeing Dreamliner operated by Air India crashed moments after taking off from Ahmedabad, India. In late 2018, Ethiopian Airlines Flight 302 — a Boeing 737 Max 8 aircraft — crashed in a rural area southeast of Addis Ababa, killing everyone on board. It came just months after another 737 Max 8 aircraft went down just after takeoff from Jakarta, Indonesia. When it comes to safety concerns, Clark insisted that Boeing has worked hard to shore up the security functions on its planes. Boeing is now focused on operational safety, quality control and reviewing systems and protocols across the board, Clark said. "If they get all of that right, it will take time, but with the new management, they have a strong chance of restoring the company to its former glory," he added. "We've got 270 now of the 777, the biggest 777 order probably in history, when you take it all together — I don't think we'd be doing that if we weren't confident they were going to be able to deliver," Clark said. "So we're right behind them. We've been moaning, as you would expect — it has not been easy or cheap for us to remediate the lack of capacity, but in the end, you have to put your faith in what I believe to be a strong and sound company that well managed, they'll get themselves out of this and rolling out airplanes at pace in the next five [to] seven years." — CNBC's Emma Graham and Leslie Josephs contributed to this article. |
|||||
|
2025-11-18 11:56
5mo ago
|
2025-11-18 06:38
5mo ago
|
This Market Selloff Has Engulfed Stocks, Crypto, Gold. How the Fed Can Stop It. | stocknewsapi |
AAAU
BAR
DBP
DGL
GLD
GLDM
IAU
OUNZ
SGOL
UGL
|
|
|
Crypto caught in broad market selloff, food, restaurant companies feeling relief, U.S.-China trade deal is fragile, and more news to start your day.
|
|||||
|
2025-11-18 11:56
5mo ago
|
2025-11-18 06:38
5mo ago
|
Topgolf Callaway sells majority stake in Topgolf to Leonard Green at $1.1 billion valuation | stocknewsapi |
MODG
|
|
|
Topgolf Callaway Brands on Tuesday agreed to sell majority stake in its Topgolf unit to private equity firm Leonard Green, in a deal valuing the business at $1.1 billion.
|
|||||
|
2025-11-18 11:56
5mo ago
|
2025-11-18 06:40
5mo ago
|
Columbia Contrarian Core Fund Q3 2025 Performance Review | stocknewsapi |
EA
EBAY
ELV
INTU
TEL
VRTX
|
|
|
SummaryThe fund underperformed its benchmark, the Russell 1000 Index, during the third quarter.Videogame producer Electronic Art’s was the top contributor during the period.Elevance Health was the top underperformer over the period. Shinsei Motions/iStock via Getty Images
The following segment was excerpted from the Columbia Contrarian Core Fund Q3 2025 Commentary. The fund underperformed its benchmark, the Russell 1000 Index, during the third quarter. The underperformance, relative to the Russell 1000, was mainly attributable to negative Recommended For You |
|||||
|
2025-11-18 11:56
5mo ago
|
2025-11-18 06:45
5mo ago
|
Scott Gottlieb, M.D., Joins UnitedHealth Group Board of Directors | stocknewsapi |
UNH
|
|
|
--(BUSINESS WIRE)--Dr. Scott Gottlieb, former U.S. Food and Drug Administration (FDA) commissioner, is joining UnitedHealth Group's (NYSE: UNH) Board of Directors, effective immediately. Dr. Gottlieb, 53, served as FDA commissioner from 2017 to 2019, where he became known for promoting transparency, strengthening patient safety and widening consumer choice. He led initiatives to modernize regulations to help foster medical innovation, promote competition in the pharmaceutical market, confront t.
|
|||||
|
2025-11-18 11:55
5mo ago
|
2025-11-18 06:45
5mo ago
|
Citi Trends Sets Date for Third Quarter 2025 Earnings Release and Conference Call | stocknewsapi |
CTRN
|
|
|
SAVANNAH, Ga.--(BUSINESS WIRE)--Citi Trends, Inc. (NASDAQ: CTRN) today announced plans to release its earnings for the third quarter 2025 before the market opens on Tuesday, December 2, 2025. Citi Trends will host a conference call on the same day at 9:00 a.m. ET. A live broadcast of Citi Trends' conference call will be available online at the Company's website, www.cititrends.com, under the Investor Relations section, on December 2, 2025, beginning at 9:00 a.m. ET. The online replay will follo.
|
|||||
|
2025-11-18 11:55
5mo ago
|
2025-11-18 06:45
5mo ago
|
NIQ Launches New Brand Traction Score Designed to Reveal How Effectively FMCG Brands Convert Shelf Presence Into Real Consumer Purchases | stocknewsapi |
NIQ
|
|
|
LONDON--(BUSINESS WIRE)--Coca-Cola has been recognised as the top FMCG brand in Western Europe for its success in driving conversions, according to NielsenIQ (NIQ)'s Brand Traction Score, a new metric that measures how effectively brands convert their shelf presence into actual consumer purchases. The NIQ Brand Traction Score combines two of NIQ's most powerful data sources: insights from its Consumer Panel, which tracks how frequently shoppers buy a brand, and its Retail Measurement data, whic.
|
|||||
|
2025-11-18 11:54
5mo ago
|
2025-11-18 06:45
5mo ago
|
Brightstar Lottery Signs Nine-Year Agreement to Continue Operation of Italy Lotto | stocknewsapi |
BRSL
|
|
|
, /PRNewswire/ -- Brightstar Lottery PLC (NYSE: BRSL) ("Brightstar" or "the Company") announced today that its subsidiary, LottoItalia S.r.l. ("LottoItalia") has signed an agreement to operate the Italy Lotto for the next nine years. In July 2025, LottoItalia, a consortium led by Brightstar (which at the time was named International Game Technology PLC) and comprised of Allwyn, Arianna 2001 and Novomatic Italia, was formally awarded the Italy Lotto license by the Agenize delle Dogane e dei Monopoli ("ADM") following a competitive bid process.
Italy Lotto is the largest fixed odds number game in the world. Brightstar (and its predecessor companies) has managed the Italy Lotto license for more than 30 years. Through this agreement, the Company will continue to manage the license until November 2034. "We are delighted to finalize our agreement with ADM and honored to continue being entrusted to operate Italy Lotto, one of world's largest lotteries," said Renato Ascoli, Brightstar CEO, Global Lottery. "We look forward to driving Lotto wager growth with new player touchpoints and digitization of the retail experience, growing iLottery sales, and providing iCasino, sports betting, and other digital games to players in Italy." Brightstar serves nearly 90 lottery customers and their players on six continents. It is the primary technology provider to 26 of the 46 lottery jurisdictions in the U.S. and eight of the world's 10 largest lotteries. About Brightstar Lottery PLC Brightstar Lottery PLC (NYSE: BRSL) is an innovative, forward-thinking global leader in lottery that builds on our renowned expertise in delivering secure technology and producing reliable, comprehensive solutions for our customers. As a premier pure play global lottery company, our best-in-class lottery operations, retail and digital solutions, and award-winning lottery games enable our customers to achieve their goals, entertain players and distribute meaningful benefits to communities. Brightstar has a well-established local presence and is a trusted partner to governments and regulators around the world, creating value by adhering to the highest standards of service, integrity, and responsibility. Brightstar has approximately 6,000 employees. For more information, please visit www.brightstarlottery.com. Cautionary Statement Regarding Forward-Looking Statements This news release may contain forward-looking statements (including within the meaning of the Private Securities Litigation Reform Act of 1995) concerning Brightstar Lottery PLC and its consolidated subsidiaries (the "Company") and other matters. These statements may discuss goals, intentions, and expectations as to future plans, trends, events, products and services, customer relationships, results of operations, or financial condition, or otherwise, based on current beliefs of the management of the Company as well as assumptions made by, and information currently available to, such management. Forward-looking statements may be accompanied by words such as "aim," "anticipate," "believe," "plan," "could," "would," "should," "shall," "continue," "estimate," "expect," "forecast," "future," "guidance," "intend," "may," "will," "possible," "potential," "predict," "project" or the negative or other variations of them. These forward-looking statements speak only as of the date on which such statements are made and are subject to various risks and uncertainties, many of which are outside the Company's control. Should one or more of these risks or uncertainties materialize, or should any of the underlying assumptions prove incorrect, actual results may differ materially from those predicted in the forward-looking statements and from past results, performance, or achievements. Therefore, you should not place undue reliance on such statements. Factors that could cause actual results to differ materially from those in the forward-looking statements include (but are not limited to) macroeconomic, regulatory and political uncertainty, including as a result of new or increased tariffs, trade wars, and other restrictions on trade between or among countries in which the Company operates, and related changes in discretionary consumer spending and behavior, fluctuations in foreign currency exchange rates, and the other factors and risks described in the Company's annual report on Form 20-F for the financial year ended December 31, 2024 and other documents filed or furnished from time to time with the SEC, which are available on the SEC's website at www.sec.gov and on the investor relations section of the Company's website at www.brightstarlottery.com. Except as required under applicable law, the Company does not assume any obligation to update these forward-looking statements. You should carefully consider these factors and other risks and uncertainties that may affect the Company's business. All forward-looking statements contained in this news release are qualified in their entirety by this cautionary statement. All subsequent written or oral forward-looking statements attributable to the Company, or persons acting on its behalf, are expressly qualified in their entirety by this cautionary statement. Contact: Mike DeAngelis, Corporate Communications, +1 (401) 392-1000, [email protected] Matteo Selva, Italian media inquiries, +39 366 6803635 James Hurley, Investor Relations, +1 (401) 392-7190 © 2025 Brightstar Lottery PLC SOURCE Brightstar Lottery PLC |
|||||
|
2025-11-18 11:54
5mo ago
|
2025-11-18 06:45
5mo ago
|
Eaton to Participate in the UBS Global Industrials and Transportation Conference on December 2 | stocknewsapi |
ETN
|
|
|
DUBLIN--(BUSINESS WIRE)--Intelligent power management company Eaton (NYSE:ETN) today announced that its Chief Executive Officer, Paulo Ruiz, will participate in the UBS Global Industrials and Transportation Conference on December 2, 2025, at 9:40 a.m. Eastern time. Mr. Ruiz will speak to investors in a fireside chat about the company's growth strategy in key end markets, such as data centers, utilities, aerospace and more. A live webcast of the event will be available on the company's Investor.
|
|||||
|
2025-11-18 11:54
5mo ago
|
2025-11-18 06:45
5mo ago
|
Movado Group, Inc. Announces Date of Conference Call and Webcast for Third Quarter Fiscal Year 2026 Results | stocknewsapi |
MOV
|
|
|
PARAMUS, N.J.--(BUSINESS WIRE)--Movado Group, Inc. (NYSE: MOV) invites investors to listen to a broadcast of the Company's conference call to discuss third quarter fiscal year 2026 earnings results on Tuesday, November 25, 2025, at 9:00 a.m. Eastern Time. A press release detailing the Company's third quarter fiscal year 2026 results will be issued before the market opens and prior to the call. The conference call will be hosted by Efraim Grinberg, Chairman and Chief Executive Officer, and Salli.
|
|||||
|
2025-11-18 11:53
5mo ago
|
2025-11-18 06:45
5mo ago
|
Caleres to Announce Third Quarter 2025 Results on December 9 | stocknewsapi |
CAL
|
|
|
ST. LOUIS--(BUSINESS WIRE)--Caleres (NYSE: CAL), a market-leading portfolio of consumer-driven footwear brands, will release its third quarter 2025 financial results before market open on Tuesday, December 9, 2025. Following the announcement, company executives will host a conference call at 10 a.m. Eastern Time to discuss the quarterly results and provide a general business update. Investors, Caleres associates, media, and the public are invited to join the call. Participants in North America.
|
|||||
|
2025-11-18 11:53
5mo ago
|
2025-11-18 06:45
5mo ago
|
Magna Mining Reports Mineral Resource Estimate for the Levack Mine in Sudbury, Ontario | stocknewsapi |
MGMNF
|
|
|
November 18, 2025 6:45 AM EST | Source: Magna Mining Inc.
Sudbury, Ontario--(Newsfile Corp. - November 18, 2025) - Magna Mining Inc. (TSXV: NICU) (OTCQX: MGMNF) (FSE: 8YD) ("Magna" or the "Company") is pleased to announce the results of a Mineral Resource Estimate ("MRE") prepared in accordance with National Instrument 43-101 - Standards of Disclosure for Mineral Projects for the past-producing Levack Mine, located in the North Range of the Sudbury Basin, Ontario, Canada (Figure 1). The Levack Mine MRE is comprised of both footwall-type deposits, which contain copper ("Cu") and precious metals including gold ("Au"), platinum ("Pt"), palladium ("Pd") and silver ("Ag"), and contact-type deposits hosting mineralization rich in nickel ("Ni") and Cu. Levack Mineral Resource Estimate Highlights (as of August 31, 2025, the cut-off for diamond drill data incorporated in the MRE): Current mineralization in the Levack Mine includes 6.1 million tonnes in the Indicated category at 3.5% copper equivalent ("CuEq"), comprised of 1.1% Cu, 1.4% Ni, 0.6 grams per tonne (g/t) Pt, 0.7 g/t Pd, 0.1 g/t Au, and 2.0 g/t Ag, as well as 5.2 million tonnes in the Inferred category at 3.6% CuEq (1.2% Cu, 1.4% Ni, 0.6 g/t Pt, 0.8 g/t Pd, 0.2 g/t Au, 2.1 g/t Ag). The high grade footwall-type deposits contain 368,000 tonnes in the Inferred category at 9.4% CuEq (5.4% Cu, 0.75% Ni, 2.9 g/t Pt, 5.4 g/t Pd, 1.5 g/t Au, and 21.0 g/t Ag), as well as 178,000 tonnes in the Indicated category at the previously-mined Morrison Footwall Cu-PGE deposit grading 15.5% CuEq (9.1% Cu, 2.4% Ni, 3.6 g/t Pt, 6.6 g/t Pd, 1.6 g/t Au, 34.2 g/t Ag), which remains open at depth. The No. 3 Footwall deposit is particularly rich in precious metals, containing 76,000 tonnes in the Inferred category grading 7.9 g/t Pt, 15.7 g/t Pd, 3.1 g/t Au and 30.3 g/t Ag, as well as 4.5% Cu and 0.7% Ni (13.4% CuEq) with important potential implications for ongoing exploration in the footwall environment. The zones of contact-type mineralization generally occur at depths of less than 750 metres (approximately 2,460 feet) and contain 5.9 million tonnes in the Indicated category grading 0.9% Cu, 1.4% Ni, and 2.1 g/t precious metals (Pt+Pd+Au+Ag), or 3.2% CuEq, as well as 4.8 million tonnes in the Inferred category at 3.2% CuEq (0.9% Cu, 1.5% Ni, 1.5 g/t precious metals (Pt+Pd+Au+Ag)). Dave King, SVP Exploration and Geoscience, stated, "Today's announcement of Magna's initial mineral resource estimate for our flagship Levack Mine in Sudbury represents an important milestone as it confirms the presence of significant mineralization, much of which can be accessed using existing infrastructure. Importantly, in addition to over 5.9 million tonnes of contact-type mineralization in the Indicated category, 178,000 tonnes of mineralization grading 15.5% CuEq remains at the Morrison Footwall Cu-PGE deposit. There also is potential to expand the Morrison deposit with further drilling as it remains open at depth. The very high grade precious metals mineralization delineated in the No. 3 Footwall deposit will be a high priority target for our ongoing exploration efforts, along with other prospective areas in the footwall environment at Levack." Jason Jessup, CEO, stated, "The results of Magna's first mineral resource estimate for the Levack Mine exceeded our expectations, particularly in terms of the grade of the remaining mineralization at the Morrison Footwall Cu-PGE deposit, and the significant tonnage of relatively shallow, contact-type nickel-copper mineralization. This resource estimate will now be used to complete a Preliminary Economic Assessment ("PEA") with the vision of utilizing a new ramp from surface to access the shallower deposits, as well as the existing shaft and loading pocket infrastructure to hoist higher grade footwall copper-precious metals ore from deeper within the mine. The contract to complete the PEA will be awarded prior to the end of the year and will be completed during 2026. In addition, we have already engaged a contractor to begin developing the scope of work to re-establish hoisting capabilities, and this work could potentially begin in early 2026. At present, there is a contract mining company working on the 3900 Level ramp to develop access to the 3600 Level between the No.2 and No.3 shaft stations. This connection is expected to be completed in Q2 2026 and will provide many benefits for footwall exploration and synergies with a neighbouring mine. The Levack Mine has quickly become the flagship project within our company and 2026 will be an exciting year as we continue to move towards a production restart while at the same time exploring for new copper-precious metals deposits in the footwall environment at the mine." The MRE was completed by Jonathan Cirelli, P.Geo, Senior Geologist of Orix Geoscience Inc. and incorporates diamond drill data up to a cut-off of August 31, 2025. Both the Indicated and Inferred resources in the Morrison Footwall Cu-PGE deposit have been constrained geologically as discrete veins that have either been defined by previous mining operations, or by multiple diamond drill intercepts. Certain mineralized intercepts around the Morrison deposit have been excluded from this MRE where their relationship to known veins has not yet been established. Follow up drilling in these areas will be incorporated into the Company's ongoing exploration program, with the goal of including these intercepts in a future MRE update. The Morrison deposit also remains open at depth, with underground drilling to test for potential extensions planned for 2026 once drill platforms have been established. Diamond drilling to target the expansion of the Inferred resource at the No. 3 Footwall deposit will also be a focus during 2026, given the significant precious metal grades outlined in the MRE (see Table 3). This MRE will serve as the basis for the completion of a PEA study by a third-party consultant. This study will further refine the potential to access the shallow, contact-type mineralization via a new ramp from surface, as was previously investigated by the Company's internal work. In addition, the PEA will also evaluate a re-start of production from the Morrison Footwall Cu-PGE deposit via the No.2 Shaft. The No.2 Shaft is currently being used to move personnel and materials in support of underground drilling, rehabilitation and new development work at Levack Mine. Work is currently underway to determine what is required to re-establish ore and waste hoisting capabilities at the No.2 Shaft. The results of the evaluation of the hoisting system could support a decision to begin the recommissioning work as early as Q1 2026. Figure 1: Location of Magna's Existing Properties, Location of Levack Mine and Key Sudbury Infrastructure. To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/8002/274933_674abd1ab4c4f937_002full.jpg Table 1: Levack Mineral Resource Estimate1 - Indicated Category, August 31, 2025 Deposit Type Category Cut-off Grade Short Tons Metric Tonnes Cu % Ni % Co % Pt (g/tonne) Pd (g/tonne) Au (g/tonne) Ag (g/tonne) CuEq % Contact Indicated 2.00% CuEq 6,535,000 5,928,000 0.89 1.41 0.05 0.46 0.56 0.07 0.99 3.18 Footwall Indicated 2.50% CuEq 197,000 178,000 9.06 2.37 0.02 3.60 6.58 1.56 34.15 15.52 Total Indicated 6,732,000 6,106,000 1.13 1.44 0.04 0.56 0.74 0.11 1.95 3.54 Table 2: Levack Mineral Resource Estimate1 - Inferred Category, August 31, 2025 Deposit Type Category Cut-off Grade Short Tons Metric Tonnes Cu % Ni % Co % Pt (g/tonne) Pd (g/tonne) Au (g/tonne) Ag (g/tonne) CuEq % Contact Inferred 2.00% CuEq 5,288,000 4,797,000 0.87 1.46 0.04 0.39 0.40 0.05 0.68 3.15 Footwall Inferred 2.50% CuEq 406,000 368,000 5.42 0.75 0.01 2.91 5.40 1.53 21.00 9.35 Total Inferred 5,694,000 5,165,000 1.19 1.41 0.04 0.57 0.76 0.16 2.13 3.59 Table 3: Levack Mineral Resource Estimate1 - Footwall Zones, August 31, 2025 Deposit Type Zone Category Cut-off Grade Short Tons Metric Tonnes Cu % Ni % Co % Pt (g/tonne) Pd (g/tonne) Au (g/tonne) Ag (g/tonne) CuEq % Footwall Keel Indicated 2.50% CuEq - - Footwall Morrison Indicated 2.50% CuEq 197,000 178,000 9.06 2.37 0.02 3.60 6.58 1.56 34.15 15.52 Footwall No.3 FW Indicated 2.50% CuEq - - Total Indicated 2.50% CuEq 197,000 178,000 9.06 2.37 0.02 3.60 6.58 1.56 34.15 15.52 Footwall Keel Inferred 2.50% CuEq 229,000 208,000 4.36 0.48 0.01 1.41 1.88 1.10 17.74 6.44 Footwall Morrison Inferred 2.50% CuEq 93,000 85,000 8.83 1.47 0.01 2.16 4.87 1.20 20.67 12.88 Footwall No.3 FW Inferred 2.50% CuEq 83,000 76,000 4.49 0.68 0.01 7.86 15.66 3.08 30.32 13.36 Total Inferred 2.50% CuEq 406,000 368,000 5.42 0.75 0.01 2.91 5.40 1.53 21.00 9.35 Table 4: Levack Mineral Resource Estimate1, Sensitivity to Cut-off Grade, August 31, 2025 Cut-off Grade Type Category Short Tons Metric Tonnes Cu % Ni % Co % Pt (g/tonne) Pd (g/tonne) Au (g/tonne) Ag (g/tonne) CuEq % 1.50% CuEq Contact Indicated 9,767,000 8,861,000 0.75 1.20 0.04 0.40 0.49 0.06 0.88 2.70 1.75% CuEq Contact Indicated 7,951,000 7,213,000 0.82 1.31 0.04 0.43 0.53 0.06 0.93 2.95 2.00% CuEq Contact Indicated 6,535,000 5,928,000 0.89 1.41 0.05 0.46 0.56 0.07 0.99 3.18 2.25% CuEq Contact Indicated 5,348,000 4,852,000 0.97 1.52 0.05 0.49 0.60 0.07 1.04 3.42 2.50% CuEq Contact Indicated 4,350,000 3,946,000 1.04 1.62 0.05 0.52 0.63 0.08 1.10 3.66 2.00% CuEq Footwall Indicated 200,000 181,000 8.94 2.34 0.02 3.55 6.48 1.53 33.74 15.30 2.25% CuEq Footwall Indicated 198,000 180,000 9.00 2.35 0.02 3.57 6.53 1.55 33.94 15.40 2.50% CuEq Footwall Indicated 197,000 178,000 9.06 2.37 0.02 3.60 6.58 1.56 34.15 15.52 2.75% CuEq Footwall Indicated 195,000 177,000 9.13 2.38 0.02 3.63 6.63 1.57 34.37 15.63 3.00% CuEq Footwall Indicated 193,000 175,000 9.21 2.40 0.02 3.66 6.69 1.58 34.60 15.76 Cut-off Grade Type Category Short Tons Metric Tonnes Cu % Ni % Co % Pt (g/tonne) Pd (g/tonne) Au (g/tonne) Ag (g/tonne) CuEq % 1.50% CuEq Contact Inferred 7,625,000 6,917,000 0.75 1.25 0.04 0.34 0.35 0.05 0.70 2.72 1.75% CuEq Contact Inferred 6,384,000 5,791,000 0.82 1.35 0.04 0.36 0.38 0.05 0.70 2.93 2.00% CuEq Contact Inferred 5,288,000 4,797,000 0.87 1.46 0.04 0.39 0.40 0.05 0.68 3.15 2.25% CuEq Contact Inferred 4,378,000 3,971,000 0.93 1.56 0.05 0.42 0.43 0.06 0.70 3.36 2.50% CuEq Contact Inferred 3,498,000 3,173,000 1.01 1.66 0.05 0.46 0.47 0.06 0.75 3.61 2.00% CuEq Footwall Inferred 448,000 406,000 5.01 0.69 0.01 2.75 5.02 1.42 19.84 8.68 2.25% CuEq Footwall Inferred 425,000 386,000 5.23 0.72 0.01 2.83 5.22 1.48 20.45 9.03 2.50% CuEq Footwall Inferred 406,000 368,000 5.42 0.75 0.01 2.91 5.40 1.53 21.00 9.35 2.75% CuEq Footwall Inferred 387,000 352,000 5.60 0.77 0.01 3.00 5.60 1.58 21.58 9.67 3.00% CuEq Footwall Inferred 364,000 330,000 5.86 0.80 0.01 3.13 5.86 1.65 22.39 10.10 1 Footnotes to the Levack Mineral Resource Estimate The effective date of the Levack Mine Mineral Resource Estimate (MRE) is August 31, 2025. This is the close out date for the final mineral resource models and mine out models (as-builts) The mineral resources are reported at a cut-off grade of 2.00% CuEq for Contact deposits and 2.50% CuEq for Footwall deposits. Values in this table reported above and below the cut-off grades should not be misconstrued with a Mineral Resource Statement. The values are only presented to show the sensitivity of the block model estimates to the selection of cut-off grade. CuEq is calculated using metal prices of $4.50/lb Cu, $7.31/lb Ni, $15.00/lb Co, $1,291/oz Pt, $1,031/oz Pd ,$3,324/oz Au, and $37.40/oz Ag. Metal recoveries considered are 91% for Cu, 85% for Ni, 68% for Co, 64% for Pt, 69.5% for Pd, 70.5% for Au, and 70% for AgThe mineral resource was estimated by Jonathan Cirelli, P.Geo. of Orix Geoscience Inc. and is an independent Qualified Person as defined by NI 43-101. A site visit was conducted on July 9th, 2025.The classification of the current Mineral Resource Estimate (MRE) into Indicated and Inferred mineral resources is consistent with current 2014 CIM Definition Standards - For Mineral Resources and Mineral Reserves.All figures are rounded to reflect the relative accuracy of the estimate and numbers may not add due to rounding.The mineral resources are presented undiluted and in situ, constrained by diamond drillhole information and previous underground geological mapping, and are considered to have reasonable prospects for eventual economic extraction. The mineral resource is exclusive of mined out material. The drillhole database includes data from 10,525 surface and underground diamond drill holes completed between 1911 and 2025. The drilling totals 4,382,756 ft (1,335,864 m) including 341,394 assay intervals representing 1,393,512 ft (424,742 m) of data.Mineral resources which are not mineral reserves do not have demonstrated economic viability. An Inferred Mineral Resource has a lower level of confidence than that applying to an Indicated Mineral Resource and must not be converted to a Mineral Reserve. It is reasonably expected that most Inferred Mineral Resources could be upgraded to Indicated Mineral Resources with continued exploration.Grades for Ni, Cu, Co, Pt, Pd, Au, and Ag are estimated for each mineralization domain using ~2.0 ft (0.61 m), 2.5 ft (0.76 m), or 5.0 ft (1.52 m) composites assigned to that domain, depending on the style of mineralization. To generate grade within the blocks, the inverse distance squared (ID2) interpolation method was used for all domains. Samples were capped before compositing when required.Reliable density measurements were available for 21% of the samples in the drillhole database (71,712 measured samples) allowing for zone-specific Ni and Cu-based regression formulas to be created and applied to estimate missing densities. Figure 2: Levack Mine Underground Development and Mineralized Zones. Oblique 3D View Looking Northwest. To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/8002/274933_674abd1ab4c4f937_007full.jpg Figure 3: Levack Mine Underground Development and Mineralized Zones. Oblique 3D View Looking Southeast. To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/8002/274933_674abd1ab4c4f937_008full.jpg The technical report in support of the above noted mineral resource estimates will be filed by Magna within 45 days of this press release. Announcement of Filing of Q3 Financials and Conference Call The Company is scheduled to release its Q3 2025 financial results and MD&A after the market close on Tuesday November 25, 2025. In addition, the Company will be holding a conference call and webcast on Wednesday November 26, 2025 at 8:00am EST. To register for the conference call, please use the following link to obtain a Dial-in Number and PIN: https://register-conf.media-server.com/register/BIfc83dc419540403380a832570e704494 To attend the webcast in listen-only mode, please use the following link: https://edge.media-server.com/mmc/p/xxh36742 Qualified Person for Technical Information The scientific and technical information in this press release has been reviewed and approved by both Jonathan Cirelli, P.Geo, Senior Geologist of Orix Geoscience Inc., independent of the Company, and David King, M.Sc., P.Geo, Senior Vice President, Exploration and Geoscience for the Company. Both Mr. Cirelli and Mr. King are qualified persons under National Instrument 43-101. Cautionary Statement on Forward-Looking Statements All statements, other than statements of historical fact, contained or incorporated by reference in this press release constitute "forward-looking statements" and "forward-looking information" (collectively, "forward-looking statements") within the meaning of applicable securities laws. Generally, these forward-looking statements can be identified by the use of forward-looking terminology, such as "may", "might", "potential", "expect", "anticipate", "estimate", "believe", "could", "should", "would", "will", "continue", "intend", "plan", "forecast", "prospective", "significant" or other similar words or phrases or variations thereof. Forward-looking statements are necessarily based upon a number of assumptions that, while considered reasonable by management, are inherently subject to business, market, economic, technical and other risks, uncertainties and contingencies that may cause actual results, performance or achievements to be materially different from those expressed or implied by forward-looking statements, including risks and uncertainties relating to the failure of additional drilling to support assumptions, expectations or estimates of potential mineralization, metal tonnes or grade, such as those related to the Morrison Deposit, the failure of additional drilling to support additional expansion or delineation of estimated resources, the failure of additional drilling to support production planning, the lack of availability of drill rigs to implement exploration or other programs or the failure to proceed as quickly as planned with additional exploration or other drilling, continued delays for assay results, the failure to proceed as quickly as planned with or to complete additional development as anticipated, such as the development of a ramp from the surface of, or recommissioning of the hoisting plant at, the Levack Mine, the failure to proceed as quickly as planned with a restart of mining at the Levack Mine, assuming there will be any restart, and other risks disclosed in the Company's annual management discussion and analysis, available on the SEDAR+ website (at: www.sedarplus.ca). Although the Company has attempted to identify important risks, uncertainties, contingencies and factors that could cause actual results to differ materially from those expressed or implied in forward-looking statements, there can be no certainty or assurance that the Company has accurately or adequately captured, accounted for or disclosed all such risks, uncertainties, contingencies or factors. Readers should place no reliance on forward-looking statements as actual results, performance or achievements may be materially different from those expressed or implied by such statements. Resource exploration and development, and mining operations, are highly speculative, characterized by several significant risks, which even a combination of careful evaluation, experience and knowledge will not eliminate. Forward-looking statements speak only as of the date they are made. The Company does not undertake to update any forward-looking statements, whether as a result of new information or future events or otherwise, except in accordance with applicable securities laws. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this press release. About Magna Mining Inc. Magna Mining Inc. is a producing mining company with a strong portfolio of copper, nickel, and platinum group metals (PGM) assets located in the world-class Sudbury mining district of Ontario, Canada. The Company's primary asset is the McCreedy West Mine, currently in production, supported by a pipeline of highly prospective past-producing properties including Levack, Crean Hill, Podolsky, and Shakespeare. Magna Mining is strategically positioned to unlock long-term shareholder value through continued production, exploration upside, and near-term development opportunities across its asset base. Additional corporate and project information is available at www.magnamining.com and through the Company's public filings on the SEDAR+ website at www.sedarplus.ca. For further information, please contact: Jason Jessup Chief Executive Officer or Paul Fowler, CFA Executive Vice President 705-482-9667 Email: [email protected] To view the source version of this press release, please visit https://www.newsfilecorp.com/release/274933 |
|||||
|
2025-11-18 11:53
5mo ago
|
2025-11-18 06:45
5mo ago
|
Investor Alert: Robbins LLP Informs Investors of the Perrigo Company Plc Class Action | stocknewsapi |
PRGO
|
|
|
, /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Perrigo Company plc (NYSE: PRGO) securities between February 27, 2024 and November 4, 2025. Perrigo provides over-the-counter health and wellness solutions in the U.S., Europe, and internationally.
For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Perrigo Company plc (PRGO) Misled Investors Regarding the Value of its Infant Formula Business According to the complaint, during the class period, defendants failed to disclose: (1) that the infant formula business acquired from Nestlé suffered from significant underinvestment in maintenance, operational improvements, and repairs; (2) that Perrigo needed to make substantial capital and operational expenditures above the Company's outwardly stated cost estimates to remediate the infant formula business; (3) that there were significant manufacturing deficiencies in the facility for the Company's infant formula business; and (4) that, as a result of the foregoing, the Company's financial results, including earnings and cash flow, were overstated. Plaintiff alleges that on November 5, 2025, Perrigo announced disappointing financial results for the third quarter ended September 27, 2025. The press release revealed that Perrigo had slashed its fiscal year 2025 outlook "due primarily to infant formula industry dynamics." The same day, Perrigo issued a press release, announcing the Company "is initiating a strategic review of its infant formula business." The press release revealed Perrigo is "reassessing the Company's previously announced investment in this business of $240 million" and that the infant formula business had become "less strategic." On this news, Perrigo's stock price fell $5.09, or 25.2%, to close at $15.10 per share on November 5, 2025. What Now: You may be eligible to participate in the class action against Perrigo Corporation plc. Shareholders who wish to serve as lead plaintiff for the class should contact Robbins LLP. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here. All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Perrigo Company plc settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today. Attorney Advertising. Past results do not guarantee a similar outcome. SOURCE Robbins LLP |
|||||
|
2025-11-18 11:53
5mo ago
|
2025-11-18 06:45
5mo ago
|
Designer Brands Inc. Announces Third Quarter 2025 Earnings Release Date | stocknewsapi |
DBI
|
|
|
, /PRNewswire/ -- Designer Brands Inc. (NYSE: DBI), one of the world's largest designers, producers and retailers of footwear and accessories, announced the Company will issue its third quarter 2025 earnings on December 9, 2025. Management will host a conference call to discuss the results at 8:30 am E.T. A press release detailing the Company's results will be issued prior to the call.
Investors and analysts interested in participating in the call are invited to dial 888-317-6003, or the international dial in, 412-317-6061, and reference conference ID number 7491258 approximately ten minutes prior to the start of the call. The conference call will be broadcast live over the internet and can be accessed through the following link: Designer Brands Inc 3Q25 Earnings Call For those unable to listen to the live webcast, an archived version will be available at the same location until December 23, 2025. A replay of the teleconference will be available by dialing the following numbers: Replay: US callers: 1-877-344-7529 Canadian callers: 1-855-669-9658 International callers: 1-412-317-0088 Passcode: 2491453 About Designer Brands Designer Brands is one of the world's largest designers, producers, and retailers of the most recognizable footwear brands and accessories, transforming and defining the footwear industry through a mission of being shoe obsessed. With a diversified, world-class portfolio of coveted brands, including Topo Athletic, Keds, Vince Camuto, Kelly & Katie, Jessica Simpson, Lucky Brand, Mix No. 6, Crown Vintage and others, Designer Brands designs and produces on-trend footwear and accessories for all of life's occasions delivered to the consumer through a robust direct-to-consumer omni-channel infrastructure and powerful national wholesale distribution. Powered by an approximately billion-dollar digital commerce business across multiple domains and over 650 DSW Designer Shoe Warehouse, The Shoe Co., and Rubino stores in North America, Designer Brands delivers current, in-line footwear and accessories from the largest national brands in the industry and holds leading market share positions in key product categories across women's, men's, and kids'. Designer Brands also distributes its brands internationally through select wholesale and distributor relationships while also leveraging design and sourcing expertise to build private label products for national retailers. Designer Brands is committed to being a difference maker in the world and the footwear industry. By leading with our corporate values of We Belong and We Do What's Right, Designer Brands supports the global community and the health of the planet by donating more than eleven million pairs of shoes to the global non-profit Soles4Souls since 2018. To learn more, visit www.designerbrands.com. SOURCE Designer Brands Inc. |
|||||
|
2025-11-18 11:53
5mo ago
|
2025-11-18 06:45
5mo ago
|
Medtronic reports strong second quarter fiscal 2026 financial results, enterprise growth drivers accelerate momentum | stocknewsapi |
MDT
|
|
|
Cardiac Ablation Solutions growth of 71% on strength of pulsed field ablation (PFA) portfolio; Raising FY26 revenue and EPS guidance
, /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its second quarter (Q2) of fiscal year 2026 (FY26), which ended October 24, 2025. Q2 Key Highlights Medtronic reports strong second quarter fiscal 2026 financial results Medtronic reports strong second quarter fiscal 2026 financial results Medtronic reports strong second quarter fiscal 2026 financial results Revenue of $9.0 billion, increased 6.6% as reported and 5.5% organic, 75 basis points above guidance midpoint GAAP diluted EPS of $1.07 increased 8%; non-GAAP diluted EPS of $1.36 increased 8%, above guidance Raising FY26 guidance: 5.5% organic revenue growth, $5.62-$5.66 adjusted EPS Strongest Cardiovascular revenue growth in over a decade, excluding pandemic Cardiac Ablation Solutions revenue increased 71%, including 128% in the U.S., on strength of pulsed field ablation (PFA) portfolio Received broad, favorable National Coverage Determination (NCD) from U.S. Centers for Medicare & Medicaid Services (CMS) and several favorable commercial payer coverage policies for the Symplicity™ procedure for the treatment of uncontrolled hypertension, or high blood pressure, with U.S. addressable market of 18 million people Secured U.S. FDA approval for the Altaviva™ device, a simple option for treating urge urinary incontinence, which affects over 16 million people in the U.S. Hugo™ robotic-assisted surgery system Enable Hernia Repair study met safety and effectiveness endpoints; initiated Embrace Gynecology US pivotal study U.S. FDA cleared the MiniMed™ 780G system to enable integration with the Instinct sensor and approved use of the MiniMed™ 780G system in Type 2 diabetes "We delivered a strong second quarter, with both revenue and EPS beating expectations. Overall, procedure volumes and our end markets are robust, and we're executing well across the business," said Geoff Martha, Medtronic chairman and chief executive officer. "Looking ahead, we are positioned for even greater acceleration of revenue growth in the back half of the year and beyond, driven by several enterprise growth drivers, including our PFA franchise for Afib, Symplicity™ procedure for hypertension, Hugo™ robotic-assisted surgery system, and Altaviva™ therapy for urge urinary incontinence." Financial Results Medtronic reported Q2 worldwide revenue of $8.961 billion, an increase of 6.6% as reported and 5.5% on an organic basis. The organic revenue growth comparison excludes: Other revenue of $35 million in the current year and $37 million in the prior year; Revenue from the Dutch Obesity Clinic (NOK) divestiture of $5 million in the current year and $16 million in the prior year; and Foreign exchange benefit of $111 million on the remaining segments. Q2 revenue by segment included: Cardiovascular Portfolio revenue of $3.436 billion, an increase of 10.8% as reported and 9.3% organic, with a mid-teens increase in Cardiac Rhythm & Heart Failure, high-single digit increase in Structural Heart & Aortic, and low-single digit increase in Coronary & Peripheral Vascular, all on an organic basis; Neuroscience Portfolio revenue of $2.562 billion, an increase of 4.5% reported and 3.9% organic, with a high-single digit increase in Neuromodulation, a mid-single digit increase in Cranial & Spinal Technologies, and flat result in Specialty Therapies, all on an organic basis; Medical Surgical Portfolio revenue of $2.171 billion, an increase of 2.1% as reported and 1.3% organic, with low-single digit organic increases in both Surgical & Endoscopy and Acute Care & Monitoring; and Diabetes business revenue of $757 million, an increase of 10.3% as reported and 7.1% organic. Q2 GAAP operating profit and operating margin were $1.686 billion and 18.8%, respectively, an increase of 6% and a decrease of 20 basis points, respectively. As detailed in the financial schedules included at the end of the release, Q2 non-GAAP operating profit and operating margin were $2.162 billion and 24.1%, respectively, an increase of 6% and a decrease of 20 basis points, respectively. Q2 GAAP net income and diluted earnings per share (EPS) were $1.374 billion and $1.07, respectively, both increases of 8%. As detailed in the financial schedules included at the end of this release, Q2 non-GAAP net income and non-GAAP diluted EPS were $1.746 billion and $1.36, respectively, both increases of 8%. Guidance The company today raised its FY26 revenue growth and EPS guidance. The company raised its FY26 organic revenue growth guidance to approximately 5.5%, an increase from the prior guidance of approximately 5.0%. The company raised its FY26 diluted non-GAAP EPS guidance to the new range of $5.62 to $5.66 versus the prior $5.60 to $5.66. This includes a potential impact from tariffs of approximately $185 million, unchanged from the prior guidance. Excluding the potential impact from tariffs, this guidance represents FY26 diluted non-GAAP EPS growth of approximately 4.5%. "In the second quarter, we drove underlying efficiency gains in our gross margin, significantly increased R&D to fuel our future growth, as well as strategically increased investment in sales and marketing for our growth programs in light of the outsized demand and building momentum for key programs," said Thierry Piéton, Medtronic chief financial officer. "Given our outperformance in the first half of the year and confidence we have in our revenue growth acceleration, we are raising today our full year revenue and EPS guidance." Video Webcast Information Medtronic will host a video webcast today, November 18, at 8:00 a.m. EST (7:00 a.m. CST) to provide information about its business for the public, investors, analysts, and news media. This webcast can be accessed by clicking on the Quarterly Earnings icon at investorrelations.medtronic.com, and this earnings release will be archived at news.medtronic.com. Within 24 hours of the webcast, a replay of the webcast and transcript of the company's prepared remarks will be available by clicking on the Past Events and Presentations link under the News & Events drop-down at investorrelations.medtronic.com. Financial Schedules and Earnings Presentation The second quarter financial schedules and non-GAAP reconciliations can be viewed by clicking on the Quarterly Earnings link at investorrelations.medtronic.com. To view a printable PDF of the financial schedules and non-GAAP reconciliations, click here. To view the second quarter earnings presentation, click here. About Medtronic Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE: MDT), visit www.Medtronic.com and follow on LinkedIn. FORWARD LOOKING STATEMENTS This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties, including risks related to competitive factors, difficulties and delays inherent in the development, manufacturing, marketing and sale of medical products, government regulation, geopolitical conflicts, changing global trade policies, material acquisition and divestiture transactions, general economic conditions, and other risks and uncertainties described in the company's periodic reports on file with the U.S. Securities and Exchange Commission including the most recent Annual Report on Form 10-K of the company. In some cases, you can identify these statements by forward-looking words or expressions, such as "anticipate," "believe," "could," "estimate," "expect," "forecast," "intend," "looking ahead," "may," "plan," "possible," "potential," "project," "should," "going to," "will," and similar words or expressions, the negative or plural of such words or expressions and other comparable terminology. Actual results may differ materially from anticipated results. Medtronic does not undertake to update its forward-looking statements or any of the information contained in this press release, including to reflect future events or circumstances. NON-GAAP FINANCIAL MEASURES This press release contains financial measures, including adjusted net income, adjusted diluted EPS, and organic revenue, which are considered "non-GAAP" financial measures under applicable SEC rules and regulations. References to quarterly or annual figures increasing, decreasing or remaining flat are in comparison to fiscal year 2025, and references to sequential changes are in comparison to the prior fiscal quarter. Unless stated otherwise, quarterly and annual rates and ranges are given on an organic basis. Medtronic management believes that non-GAAP financial measures provide information useful to investors in understanding the company's underlying operational performance and trends and to facilitate comparisons with the performance of other companies in the med tech industry. Non-GAAP net income and diluted EPS exclude the effect of certain charges or gains that contribute to or reduce earnings but that result from transactions or events that management believes may or may not recur with similar materiality or impact to operations in future periods (Non-GAAP Adjustments). Medtronic generally uses non-GAAP financial measures to facilitate management's review of the operational performance of the company and as a basis for strategic planning. Non-GAAP financial measures should be considered supplemental to and not a substitute for financial information prepared in accordance with U.S. generally accepted accounting principles (GAAP), and investors are cautioned that Medtronic may calculate non-GAAP financial measures in a way that is different from other companies. Management strongly encourages investors to review the company's consolidated financial statements and publicly filed reports in their entirety. Reconciliations of the non-GAAP financial measures to the most directly comparable GAAP financial measures are included in the financial schedules accompanying this press release. Medtronic calculates forward-looking non-GAAP financial measures based on internal forecasts that omit certain amounts that would be included in GAAP financial measures. For instance, forward-looking organic revenue growth guidance excludes the impact of foreign currency fluctuations, as well as significant acquisitions, divestitures, or other significant discrete items. Forward-looking diluted non-GAAP EPS guidance also excludes other potential charges or gains that would be recorded as Non-GAAP Adjustments to earnings during the fiscal year. Medtronic does not attempt to provide reconciliations of forward-looking non-GAAP EPS guidance to projected GAAP EPS guidance because the combined impact and timing of recognition of these potential charges or gains is inherently uncertain and difficult to predict and is unavailable without unreasonable efforts. In addition, the company believes such reconciliations would imply a degree of precision and certainty that could be confusing to investors. Such items could have a substantial impact on GAAP measures of financial performance. Contacts: Erika Winkels Public Relations +1-763-526-8478 Ryan Weispfenning Investor Relations +1-763-505-4626 MEDTRONIC PLC WORLD WIDE REVENUE(1) (Unaudited) SECOND QUARTER YEAR-TO-DATE REPORTED ORGANIC REPORTED ORGANIC (in millions) FY26 FY25 Growth Currency Impact(4) FY26(5) FY25(5) Growth FY26 FY25 Growth Currency Impact(4) FY26(6) FY25(6) Growth Cardiovascular $ 3,436 $ 3,102 10.8 % $ 46 $ 3,390 $ 3,102 9.3 % $ 6,721 $ 6,108 10.0 % $ 114 $ 6,607 $ 6,108 8.2 % Cardiac Rhythm & Heart Failure 1,825 1,578 15.7 22 1,804 1,578 14.3 3,538 3,114 13.6 58 3,479 3,114 11.7 Structural Heart & Aortic 956 881 8.5 17 939 881 6.6 1,885 1,736 8.6 39 1,847 1,736 6.4 Coronary & Peripheral Vascular 655 643 1.9 7 648 643 0.8 1,298 1,259 3.1 17 1,281 1,259 1.8 Neuroscience 2,562 2,451 4.5 15 2,546 2,451 3.9 4,978 4,768 4.4 43 4,935 4,768 3.5 Cranial & Spinal Technologies 1,299 1,234 5.2 6 1,293 1,234 4.7 2,509 2,382 5.4 18 2,492 2,382 4.6 Specialty Therapies 744 737 0.9 5 739 737 0.3 1,446 1,450 (0.3) 13 1,432 1,450 (1.2) Neuromodulation 520 480 8.3 5 515 480 7.3 1,023 937 9.2 12 1,011 937 7.9 Medical Surgical 2,171 2,128 2.1 27 2,139 2,111 1.3 4,255 4,123 3.2 67 4,183 4,107 1.8 Surgical & Endoscopy 1,679 1,649 1.8 23 1,651 1,633 1.1 3,291 3,193 3.0 55 3,231 3,177 1.7 Acute Care & Monitoring 493 478 3.0 4 488 478 2.0 964 930 3.6 12 952 930 2.3 Diabetes 757 686 10.3 22 735 686 7.1 1,478 1,333 10.9 45 1,433 1,333 7.5 Total Reportable Segments 8,926 8,366 6.7 111 8,811 8,350 5.5 17,432 16,333 6.7 270 17,158 16,317 5.2 Other(2) 35 37 (5.8) — — — — 107 (15) NM(3) 3 — — — TOTAL $ 8,961 $ 8,403 6.6 % $ 111 $ 8,811 $ 8,350 5.5 % $ 17,539 $ 16,318 7.5 % $ 273 $ 17,158 $ 16,317 5.2 % (1) The data in this schedule has been intentionally rounded to the nearest million and, therefore, may not sum. Percentages have been calculated using actual, non-rounded figures and, therefore, may not recalculate precisely. (2) Includes the historical operations and ongoing transition agreements from businesses the Company has exited or divested, and for the year-to-date figures, adjustments to the Company's Italian payback accruals resulting from the two July 22, 2024 rulings by the Constitutional Court and the Legislative Decree published by the Italian government on June 30, 2025 for certain prior years since 2015. (3) Not meaningful (NM). (4) The currency impact to revenue measures the change in revenue between current and prior year periods using constant exchange rates. (5) The three months ended October 24, 2025 excludes $151 million of revenue adjustments, including $35 million of inorganic revenue for the transition activity noted in (2), $5 million of inorganic revenue related to a sale of business in the Surgical and Endoscopy division, and $111 million of favorable currency impact on the remaining segments. The three months ended October 25, 2024 excludes $53 million of revenue adjustments, including $37 million of inorganic revenue related to the transition activity noted in (2) and $16 million of inorganic revenue related to a sale of business in the Surgical and Endoscopy division. (6) The six months ended October 24, 2025 excludes $382 million of revenue adjustments, including $39 million reduction in the Italian payback accruals due to changes in estimates further described in note (2), $68 million of inorganic revenue for the transition activity noted in (2), $5 million of inorganic revenue related to a sale of business in the Surgical and Endoscopy division, and $270 million of favorable currency impact on the remaining segments. The six months ended October 25, 2024 excludes $1 million of revenue adjustments related to $90 million of incremental Italian payback accruals further described in note (2), $75 million of inorganic revenue related to the transition activity noted in (2), and $16 million of inorganic revenue related to a sale of business in the Surgical and Endoscopy division. MEDTRONIC PLC U.S. REVENUE(1)(2) (Unaudited) SECOND QUARTER YEAR-TO-DATE REPORTED ORGANIC REPORTED ORGANIC (in millions) FY26 FY25 Growth FY26 FY25 Growth FY26 FY25 Growth FY26 FY25 Growth Cardiovascular $ 1,592 $ 1,434 11.0 % $ 1,592 $ 1,434 11.0 % $ 3,071 $ 2,836 8.3 % $ 3,071 $ 2,836 8.3 % Cardiac Rhythm & Heart Failure 920 768 19.9 920 768 19.9 1,754 1,534 14.4 1,754 1,534 14.4 Structural Heart & Aortic 390 388 0.4 390 388 0.4 761 757 0.6 761 757 0.6 Coronary & Peripheral Vascular 282 278 1.4 282 278 1.4 556 546 1.7 556 546 1.7 Neuroscience 1,730 1,677 3.1 1,730 1,677 3.1 3,354 3,242 3.4 3,354 3,242 3.4 Cranial & Spinal Technologies 966 926 4.4 966 926 4.4 1,857 1,781 4.2 1,857 1,781 4.2 Specialty Therapies 409 418 (2.2) 409 418 (2.2) 801 816 (1.8) 801 816 (1.8) Neuromodulation 355 333 6.4 355 333 6.4 695 645 7.9 695 645 7.9 Medical Surgical 943 944 (0.1) 943 944 (0.1) 1,827 1,825 0.1 1,827 1,825 0.1 Surgical & Endoscopy 665 675 (1.5) 665 675 (1.5) 1,286 1,304 (1.4) 1,286 1,304 (1.4) Acute Care & Monitoring 278 269 3.4 278 269 3.4 541 521 3.9 541 521 3.9 Diabetes 230 232 (0.8) 230 232 (0.8) 447 447 — 447 447 — Total Reportable Segments 4,494 4,286 4.8 4,494 4,286 4.8 8,699 8,350 4.2 8,699 8,350 4.2 Other(3) 22 18 21.9 — — — 42 37 14.1 — — — TOTAL $ 4,516 $ 4,304 4.9 % $ 4,494 $ 4,286 4.8 % $ 8,741 $ 8,387 4.2 % $ 8,699 $ 8,350 4.2 % (1) U.S. includes the United States and U.S. territories. (2) The data in this schedule has been intentionally rounded to the nearest million and, therefore, may not sum. Percentages have been calculated using actual, non-rounded figures and, therefore, may not recalculate precisely. (3) Includes historical operations and ongoing transition agreements from businesses the Company has exited or divested. MEDTRONIC PLC INTERNATIONAL REVENUE(1) (Unaudited) SECOND QUARTER YEAR-TO-DATE REPORTED ORGANIC REPORTED ORGANIC (in millions) FY26 FY25 Growth Currency Impact(4) FY26(5) FY25(5) Growth FY26 FY25 Growth Currency Impact(4) FY26(6) FY25(6) Growth Cardiovascular $ 1,844 $ 1,668 10.6 % $ 46 $ 1,799 $ 1,668 7.8 % $ 3,650 $ 3,272 11.6 % $ 114 $ 3,536 $ 3,272 8.1 % Cardiac Rhythm & Heart Failure 905 811 11.7 22 883 811 9.0 1,784 1,580 12.9 58 1,725 1,580 9.2 Structural Heart & Aortic 566 492 14.9 17 549 492 11.5 1,124 980 14.8 39 1,085 980 10.8 Coronary & Peripheral Vascular 373 365 2.3 7 366 365 0.3 743 713 4.2 17 726 713 1.8 Neuroscience 832 774 7.5 15 817 774 5.5 1,624 1,526 6.4 43 1,582 1,526 3.6 Cranial & Spinal Technologies 332 308 7.8 6 326 308 5.9 652 600 8.7 18 635 600 5.8 Specialty Therapies 335 319 4.9 5 330 319 3.5 644 634 1.6 13 631 634 (0.4) Neuromodulation 165 146 12.7 5 160 146 9.2 328 292 12.3 12 316 292 8.1 Medical Surgical 1,228 1,183 3.8 27 1,196 1,167 2.5 2,427 2,298 5.6 67 2,356 2,282 3.2 Surgical & Endoscopy 1,014 974 4.1 23 987 958 3.0 2,004 1,889 6.1 55 1,945 1,873 3.9 Acute Care & Monitoring 214 209 2.5 4 210 209 0.3 423 409 3.3 12 411 409 0.3 Diabetes 527 455 16.0 22 505 455 11.1 1,031 886 16.4 45 986 886 11.2 Total Reportable Segments 4,432 4,080 8.6 111 4,317 4,064 6.2 8,733 7,983 9.4 270 8,459 7,966 6.2 Other(2) 13 19 (32.4) — — — — 65 (51) NM(3) 3 — — — TOTAL $ 4,445 $ 4,099 8.4 % $ 111 $ 4,317 $ 4,064 6.2 % $ 8,799 $ 7,931 10.9 % $ 273 $ 8,459 $ 7,966 6.2 % (1) The data in this schedule has been intentionally rounded to the nearest million and, therefore, may not sum. Percentages have been calculated using actual, non-rounded figures and, therefore, may not recalculate precisely. (2) Includes the historical operations and ongoing transition agreements from businesses the Company has exited or divested, and for the year-to-date figures, adjustments to the Company's Italian payback accruals resulting from the two July 22, 2024 rulings by the Constitutional Court and the Legislative Decree published by the Italian government on June 30, 2025 for certain prior years since 2015. (3) Not meaningful (NM). (4) The currency impact to revenue measures the change in revenue between current and prior year periods using constant exchange rates. (5) The three months ended October 24, 2025 excludes $128 million of revenue adjustments, including $13 million of inorganic revenue for the transition activity noted in (2), $5 million of inorganic revenue related to a sale of business in the Surgical and Endoscopy division, and $111 million of favorable currency impact on the remaining segments. The three months ended October 25, 2024 excludes $35 million of revenue adjustments, including $19 million of inorganic revenue related to the transition activity noted in (2) and $16 million of inorganic revenue related to a sale of business in the Surgical and Endoscopy division. (6) The six months ended October 24, 2025 excludes $340 million of revenue adjustments, including $39 million reduction in the Italian payback accruals due to changes in estimates further described in note (2), $27 million of inorganic revenue for the transition activity noted in (2), $5 million of inorganic revenue related to a sale of business in the Surgical and Endoscopy division, and $270 million of favorable currency impact on the remaining segments. The six months ended October 25, 2024 excludes $35 million of revenue adjustments related to $90 million of incremental Italian payback accruals further described in note (2), $38 million of inorganic revenue related to the transition activity noted in (2), and $16 million of inorganic revenue related to a sale of business in the Surgical and Endoscopy division. MEDTRONIC PLC CONSOLIDATED STATEMENTS OF INCOME (Unaudited) Three months ended Six months ended (in millions, except per share data) October 24, 2025 October 25, 2024 October 24, 2025 October 25, 2024 Net sales $ 8,961 $ 8,403 $ 17,539 $ 16,318 Costs and expenses: Cost of products sold, excluding amortization of intangible assets 3,061 2,946 6,062 5,707 Research and development expense 754 697 1,480 1,373 Selling, general, and administrative expense 2,965 2,757 5,772 5,412 Amortization of intangible assets 463 413 922 827 Restructuring charges, net 10 30 55 77 Certain litigation charges, net — — 27 81 Other operating expense (income), net 22 (34) 92 (33) Operating profit 1,686 1,595 3,130 2,873 Other non-operating income, net (92) (173) (125) (330) Interest expense, net 181 209 357 376 Income before income taxes 1,597 1,559 2,898 2,827 Income tax provision 215 281 470 500 Net income 1,381 1,278 2,428 2,327 Net income attributable to noncontrolling interests (7) (9) (14) (15) Net income attributable to Medtronic $ 1,374 $ 1,270 $ 2,414 $ 2,312 Basic earnings per share $ 1.07 $ 0.99 $ 1.88 $ 1.79 Diluted earnings per share $ 1.07 $ 0.99 $ 1.87 $ 1.79 Basic weighted average shares outstanding 1,282.0 1,282.4 1,281.8 1,288.6 Diluted weighted average shares outstanding 1,288.0 1,286.9 1,287.5 1,292.5 The data in the schedule above has been intentionally rounded to the nearest million. MEDTRONIC PLC GAAP TO NON-GAAP RECONCILIATIONS(1) (Unaudited) Three months ended October 24, 2025 (in millions, except per share data) Net Sales Cost of Products Sold Gross Margin Percent Operating Profit Operating Profit Percent Income Before Income Taxes Net Income attributable to Medtronic Diluted EPS Effective Tax Rate GAAP $ 8,961 $ 3,061 65.8 % $ 1,686 18.8 % $ 1,597 $ 1,374 $ 1.07 13.5 % Non-GAAP Adjustments: Amortization of intangible assets(2) — — — 463 5.2 463 376 0.29 18.8 Restructuring and associated costs(3) — — — 13 0.1 13 9 0.01 23.1 Acquisition and divestiture-related items(4) — (9) 0.1 — — — (8) (0.01) — (Gain)/loss on minority investments(5) — — — — — 24 24 0.02 — Certain tax adjustments, net(6) — — — — — — (29) (0.02) — Non-GAAP $ 8,961 $ 3,052 65.9 % $ 2,162 24.1 % $ 2,097 $ 1,746 $ 1.36 16.4 % Currency impact (111) 50 (1.0) (93) (0.7) (0.06) Currency Adjusted $ 8,850 $ 3,102 64.9 % $ 2,070 23.4 % $ 1.30 Three months ended October 25, 2024 (in millions, except per share data) Net Sales Cost of Products Sold Gross Margin Percent Operating Profit Operating Profit Percent Income Before Income Taxes Net Income attributable to Medtronic Diluted EPS Effective Tax Rate GAAP $ 8,403 $ 2,946 64.9 % $ 1,595 19.0 % $ 1,559 $ 1,270 $ 0.99 18.0 % Non-GAAP Adjustments: Amortization of intangible assets — — — 413 4.9 413 338 0.26 18.2 Restructuring and associated costs(3) — (11) 0.1 46 0.5 46 37 0.03 19.6 Acquisition and divestiture-related items(4) — (5) 0.1 (25) (0.3) (25) (30) (0.02) (20.0) (Gain)/loss on minority investments(5) — — — — — (10) (21) (0.02) (100.0) Medical device regulations(7) — (9) 0.1 12 0.1 12 10 0.01 16.7 Certain tax adjustments, net — — — — — — 16 0.01 — Non-GAAP $ 8,403 $ 2,921 65.2 % $ 2,041 24.3 % $ 1,995 $ 1,620 $ 1.26 18.3 % See description of non-GAAP financial measures contained in the press release dated November 18, 2025. (1) The data in this schedule has been intentionally rounded to the nearest million or $0.01 for EPS figures, and, therefore, may not sum. (2) The Company recognized $46 million of accelerated amortization on certain intangible assets within the Cardiovascular Portfolio. (3) The charges primarily relate to employee termination benefits and facility related and contract termination costs. (4) The charges primarily include business combination costs, changes in fair value of contingent consideration, exit of business-related charges, and gains related to certain business or asset sales. Exit of business-related charges primarily relate to the impending separation of the Diabetes business and costs associated with the Company's June 2021 decision to stop the distribution and sale of the Medtronic HVAD System. (5) We exclude unrealized and realized gains and losses on our minority investments as we do not believe that these components of income or expense have a direct correlation to our ongoing or future business operations. (6) Primarily includes a tax benefit recognized due to a change in interest accrued on uncertain tax positions, partially offset by amortization of previously established deferred tax assets arising from intercompany intellectual property transactions. (7) The charges represent incremental costs of complying with the new European Union (E.U.) medical device regulations for previously registered products and primarily include charges for contractors supporting the project and other direct third-party expenses. We consider these costs to be duplicative of previously incurred costs and/or one-time costs. MEDTRONIC PLC GAAP TO NON-GAAP RECONCILIATIONS(1) (Unaudited) Six months ended October 24, 2025 (in millions, except per share data) Net Sales Cost of Products Sold Gross Margin Percent Operating Profit Operating Profit Percent Income Before Income Taxes Net Income attributable to Medtronic Diluted EPS Effective Tax Rate GAAP $ 17,539 $ 6,062 65.4 % $ 3,130 17.8 % $ 2,898 $ 2,414 $ 1.87 16.2 % Non-GAAP Adjustments: Amortization of intangible assets(2) — — — 922 5.4 922 750 0.58 18.7 Restructuring and associated costs(3) — (16) 0.1 79 0.5 79 61 0.05 24.1 Acquisition and divestiture-related items(4) — (16) 0.1 58 0.3 58 40 0.03 31.0 Certain litigation charges, net — — — 27 0.2 27 21 0.02 22.2 (Gain)/loss on minority investments(5) — — — — — 137 130 0.10 5.1 Other(6) (39) — (0.2) (39) (0.2) (39) (30) (0.02) 20.5 Certain tax adjustments, net(7) — — — — — — (13) (0.01) — Non-GAAP $ 17,501 $ 6,031 65.5 % $ 4,179 23.9 % $ 4,084 $ 3,372 $ 2.62 17.1 % Currency impact (270) 4 (0.5) (103) (0.2) (0.06) Currency Adjusted $ 17,230 $ 6,035 65.0 % $ 4,076 23.7 % $ 2.56 Six months ended October 25, 2024 (in millions, except per share data) Net Sales Cost of Products Sold Gross Margin Percent Operating Profit Operating Profit Percent Income Before Income Taxes Net Income attributable to Medtronic Diluted EPS Effective Tax Rate GAAP $ 16,318 $ 5,707 65.0 % $ 2,873 17.6 % $ 2,827 $ 2,312 $ 1.79 17.7 % Non-GAAP Adjustments: Amortization of intangible assets — — — 827 4.9 827 678 0.52 18.0 Restructuring and associated costs(3) — (20) 0.1 108 0.6 108 87 0.07 19.4 Acquisition and divestiture-related items(4) — (16) 0.1 (13) (0.1) (13) (19) (0.01) (46.2) Certain litigation charges, net — — — 81 0.5 81 68 0.05 16.0 (Gain)/loss on minority investments(5) — — — — — (27) (38) (0.03) (37.0) Medical device regulations(8) — (20) 0.1 27 0.2 27 22 0.02 18.5 Other(6) 90 — 0.4 90 0.5 90 70 0.05 22.2 Certain tax adjustments, net(7) — — — — — — 33 0.03 — Non-GAAP $ 16,408 $ 5,651 65.6 % $ 3,993 24.3 % $ 3,921 $ 3,213 $ 2.49 17.7 % See description of non-GAAP financial measures contained in the press release dated November 18, 2025. (1) The data in this schedule has been intentionally rounded to the nearest million or $0.01 for EPS figures, and, therefore, may not sum. (2) The Company recognized $91 million of accelerated amortization on certain intangible assets within the Cardiovascular Portfolio. (3) The charges primarily relate to employee termination benefits and facility related and contract termination costs. (4) The charges primarily include business combination costs, changes in fair value of contingent consideration, exit of business-related charges, and gains related to certain business or asset sales. Exit of business-related charges primarily relate to the impending separation of the Diabetes business and costs associated with the Company's June 2021 decision to stop the distribution and sale of the Medtronic HVAD System. (5) We exclude unrealized and realized gains and losses on our minority investments as we do not believe that these components of income or expense have a direct correlation to our ongoing or future business operations. (6) Reflects adjustments to the Company's Italian payback accruals resulting from the two July 22, 2024 rulings by the Constitutional Court and the Legislative Decree published by the Italian government on June 30, 2025 for certain prior years since 2015. (7) The net benefit for the six months ended October 24, 2025 primarily includes a tax benefit recognized due to a change in interest accrued on uncertain tax positions, partially offset by amortization of previously established deferred tax assets arising from intercompany intellectual property transactions. The charges for the six months ended October 25, 2024 primarily includes amortization of previously established deferred tax assets arising from intercompany intellectual property transactions. (8) The charges represent incremental costs of complying with the new European Union (E.U.) medical device regulations for previously registered products and primarily include charges for contractors supporting the project and other direct third-party expenses. We consider these costs to be duplicative of previously incurred costs and/or one-time costs. MEDTRONIC PLC GAAP TO NON-GAAP RECONCILIATIONS(1) (Unaudited) Three months ended October 24, 2025 (in millions) Net Sales SG&A Expense SG&A Expense as a % of Net Sales R&D Expense R&D Expense as a % of Net Sales Other Operating (Income) Expense, net Other Operating (Inc.)/Exp., net as a % of Net Sales Other Non- Operating Income, net GAAP $ 8,961 $ 2,965 33.1 % $ 754 8.4 % $ 22 0.2 % $ (92) Non-GAAP Adjustments: Restructuring and associated costs(2) — (3) — — — — — — Acquisition and divestiture-related items(3) — (35) (0.4) — — 43 0.5 — (Gain)/loss on minority investments(4) — — — — — — — (24) Non-GAAP $ 8,961 $ 2,927 32.7 % $ 755 8.4 % $ 64 0.7 % $ (116) Six months ended October 24, 2025 (in millions) Net Sales SG&A Expense SG&A Expense as a % of Net Sales R&D Expense R&D Expense as a % of Net Sales Other Operating (Income) Expense, net Other Operating (Inc.)/Exp., net as a % of Net Sales Other Non- Operating Income, net GAAP $ 17,539 $ 5,772 32.9 % $ 1,480 8.4 % $ 92 0.5 % $ (125) Non-GAAP Adjustments: Restructuring and associated costs(2) — (8) — — — — — — Acquisition and divestiture-related items(3) — (61) (0.3) — — 18 0.1 — Other(5) (39) — — — — — — — (Gain)/loss on minority investments(4) — — — — — — — (137) Non-GAAP $ 17,501 $ 5,702 32.6 % $ 1,480 8.5 % $ 108 0.6 % $ (262) See description of non-GAAP financial measures contained in the press release dated November 18, 2025. (1) The data in this schedule has been intentionally rounded to the nearest million, and, therefore, may not sum. (2) The charges primarily relate to employee termination benefits and facility related and contract termination costs. (3) The charges primarily include business combination costs, changes in fair value of contingent consideration, exit of business-related charges, and a gain related to a certain business sale. Exit of business-related charges primarily relate to the impending separation of the Diabetes business and costs associated with the Company's June 2021 decision to stop the distribution and sale of the Medtronic HVAD System. (4) We exclude unrealized and realized gains and losses on our minority investments as we do not believe that these components of income or expense have a direct correlation to our ongoing or future business operations. (5) Reflects adjustments to the Company's Italian payback accruals resulting from the Legislative Decree published by the Italian government on June 30, 2025 for certain prior years since 2015. MEDTRONIC PLC GAAP TO NON-GAAP RECONCILIATIONS(1) (Unaudited) Six months ended (in millions) October 24, 2025 October 25, 2024 Net cash provided by operating activities $ 2,013 $ 1,944 Additions to property, plant, and equipment (972) (924) Free Cash Flow(2) $ 1,041 $ 1,020 See description of non-GAAP financial measures contained in the press release dated November 18, 2025. (1) The data in this schedule has been intentionally rounded to the nearest million, and, therefore, may not sum. (2) Free cash flow represents operating cash flows less property, plant, and equipment additions. MEDTRONIC PLC CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Six months ended (in millions) October 24, 2025 October 25, 2024 Operating Activities: Net income $ 2,428 $ 2,327 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 1,493 1,337 Provision for credit losses 66 45 Deferred income taxes 160 57 Stock-based compensation 268 242 Other, net 167 (98) Change in operating assets and liabilities, net of acquisitions and divestitures: Accounts receivable, net 74 (181) Inventories (672) (278) Accounts payable and accrued liabilities (780) (707) Other operating assets and liabilities (1,191) (800) Net cash provided by operating activities 2,013 1,944 Investing Activities: Additions to property, plant, and equipment (972) (924) Purchases of investments (4,201) (4,019) Sales and maturities of investments 3,958 4,338 Other investing activities, net 14 1 Net cash used in investing activities (1,201) (604) Financing Activities: Change in current debt obligations, net 1,402 (67) Issuance of long-term debt 1,747 3,209 Payments on long-term debt (2,930) — Dividends to shareholders (1,820) (1,795) Issuance of ordinary shares 255 232 Repurchase of ordinary shares (495) (2,780) Other financing activities, net 65 (64) Net cash used in financing activities (1,776) (1,265) Effect of exchange rate changes on cash and cash equivalents 28 35 Net change in cash and cash equivalents (936) 110 Cash and cash equivalents at beginning of period 2,218 1,284 Cash and cash equivalents at end of period $ 1,282 $ 1,394 Supplemental Cash Flow Information Cash paid for: Income taxes $ 1,394 $ 1,335 Interest 542 513 The data in this schedule has been intentionally rounded to the nearest million, and, therefore, may not sum. SOURCE Medtronic plc |
|||||
|
2025-11-18 11:53
5mo ago
|
2025-11-18 06:47
5mo ago
|
Medtronic beats second-quarter estimates on strength in heart devices segment | stocknewsapi |
MDT
|
|
|
Medical device maker Medtronic topped Wall Street estimates for second-quarter profit and revenue on Tuesday, driven by strong demand for its heart disease and diabetes devices.
|
|||||
|
2025-11-18 11:53
5mo ago
|
2025-11-18 06:48
5mo ago
|
GE HealthCare Technologies Inc. (GEHC) Presents at Jefferies London Healthcare Conference 2025 Transcript | stocknewsapi |
GEHC
|
|
|
GE HealthCare Technologies Inc. ( GEHC ) Jefferies London Healthcare Conference 2025 November 18, 2025 4:30 AM EST Company Participants James Saccaro - VP & CFO Carolynne Borders - Chief Investor Relations Officer Conference Call Participants Matthew Taylor - Jefferies LLC, Research Division Presentation Matthew Taylor Jefferies LLC, Research Division Thanks for joining us here at the Jefferies Global Healthcare Conference, the JPMorgan of the East. So I'm Matt Taylor, the U.S. Medical supplies and devices analyst here at Jefferies, and I'm joined by the management team from GE Healthcare.
|
|||||
|
2025-11-18 11:53
5mo ago
|
2025-11-18 06:50
5mo ago
|
Energizer Holdings, Inc. Announces Fiscal 2025 Fourth Quarter and Full Year Results and Financial Outlook for Fiscal 2026 | stocknewsapi |
ENR
|
|
|
Full Year Results
Net sales increased 2.3% driven by Acquisition Net sales of $63.6 million and Organic Net sales growth of 0.7%(1) Reported EPS of $3.32 & Adjusted EPS of $3.52, an increase of 6% on an adjusted basis (1) Net earnings of $239.0 million & Adjusted EBITDA of $623.6 million (1) Project Momentum surpassed over $200 million in savings during the three-year program Extending Project Momentum to a fourth year, with a focus on ongoing tariff mitigation, increasing operational efficiency and the integration of the APS business Fourth Quarter Results Net sales increased 3.4% to $832.8 million driven by Acquisition Net sales of $42.8 million partially offset by Organic Net sales decline of 2.2%(1) Reported EPS of $0.50 & Adjusted EPS of $1.05(1) , /PRNewswire/ -- Energizer Holdings, Inc. (NYSE: ENR) today announced results for the fourth fiscal quarter and full fiscal year, which ended September 30, 2025. "Energizer delivered strong earnings in Fiscal 2025 by staying agile and focused in a volatile environment," said Mark LaVigne, Chief Executive Officer. "We adjusted quickly, found opportunities, and executed with discipline to deliver a strong year. As we begin Fiscal 2026, we are operating through a period of transition, with the first quarter more heavily affected by temporary tariff costs and mitigation efforts. However, we have responded decisively. By extending Project Momentum and accelerating integration efforts, we will preserve margins and build flexibility to invest in future growth. With resilient categories, trusted brands, and a clear strategy, we are well-positioned to build on our success and accelerate performance as the year progresses." Top-Line Performance Net sales were $832.8 million for the fourth fiscal quarter compared to $805.7 million in the prior year period and $2,952.7 million for the fiscal year compared to $2,887.0 million for the prior fiscal year. Fourth Quarter % Chg Full Fiscal Year % Chg Net sales - FY'24 $ 805.7 $ 2,887.0 Organic (17.4) (2.2) % 19.8 0.7 % Acquisition impact 42.8 5.3 % 63.6 2.2 % Change in highly inflationary markets (2.8) (0.3) % (5.3) (0.2) % Impact of currency 4.5 0.6 % (12.4) (0.4) % Net sales - FY'25 $ 832.8 3.4 % $ 2,952.7 2.3 % For the fourth fiscal quarter, organic Net sales decreased 2.2% from the prior year due to the following items: (1) Volumes declined 2.9% due to softer consumer demand, primarily in North America, partially offset by growth in e-commerce and international markets in Batteries & Lights, and new innovation and expanded distribution in Auto Care. Partially offsetting the volume declines were pricing increases of 0.7% driven by innovation and tariffs across both segments. For the fiscal year, organic Net sales increased 0.7% due to the following items: (1) Volumes grew 1.5% driven by new and expanded distribution and growth in e-commerce, as well as new innovation in Auto Care, partially offset by lower back-half category volumes as softer consumer demand impacted both segments. Offsetting the volume growth were pricing declines of 0.8% driven by planned strategic pricing and promotional investments partially offset by innovation and tariff pricing. Gross Margin Gross margin percentage on a reported basis for the fourth fiscal quarter was 36.6%, versus 38.1% in the prior year quarter. Excluding the current and prior year restructuring costs, network transition costs and integration costs, Adjusted Gross margin was 38.5%, down 370 basis points from the prior year quarter.(1) Gross margin percentage on a reported basis for fiscal 2025 was 41.7%, versus 38.3% in the prior year. Excluding the FY23 & FY24 production credits recorded in the current year, the current and prior year restructuring costs, network transition costs and integration costs, Adjusted Gross margin was 40.9% and consistent with prior year.(1) Fourth Quarter Full Fiscal Year Gross margin - FY'24 Reported 38.1 % 38.3 % Prior year impact of restructuring, network transition and integration costs 4.1 % 2.6 % Adjusted Gross margin - FY'24 (1) 42.2 % 40.9 % FY25 production credits 1.0 % 1.4 % Project Momentum initiatives 0.7 % 1.7 % Pricing 0.4 % (0.5) % Product cost impacts (2.2) % (1.4) % Tariffs (2.1) % (0.5) % Acquisition impact (1.0) % (0.4) % Currency impact, including highly inflationary markets (0.5) % (0.3) % Gross margin - FY'25 Adjusted 38.5 % 40.9 % Current year impact of restructuring, network transition and integration costs and FY23 & FY24 production credits (1.9) % 0.8 % Gross margin - FY'25 Reported 36.6 % 41.7 % Adjusted Gross margin declined in the fourth fiscal quarter driven by increased input costs from production inefficiencies associated with rebalancing our network and increased warehousing, distribution and tariff costs, as well as the lower margin profile of the APS business. These declines were partially offset by the FY25 production tax credit of $7.7 million and the Project Momentum initiatives, which delivered savings of approximately $6 million, as well as benefits from price increases implemented to offset tariff impacts. Adjusted Gross margin was flat to fiscal 2024. The benefits from the FY25 production credit of $41.6 million and the Project Momentum initiatives, which delivered savings of approximately $50 million, were fully offset by the full year impact from increased product costs from production inefficiencies associated with rebalancing our network and increased warehousing, distribution and tariff costs, as well as the lower margin profile of the APS business and the planned strategic pricing and promotional investments noted above. Selling, General and Administrative Expense (SG&A) SG&A for the fourth fiscal quarter was 15.4% of Net sales, or $128.2 million, as compared to 15.3% of Net sales, or $123.0 million, in the prior year when excluding restructuring and related costs, acquisition and integration costs and a litigation matter. The year-over-year increase was primarily driven by increased SG&A from the APS business of $7.3 million, increased investment in digital transformation and increased recycling fees. These increases were partially offset by savings from Project Momentum of approximately $4 million.(1) SG&A for fiscal 2025 was $495.5 million, or 16.8% of Net sales, as compared to $473.1 million, or 16.4% of Net sales, in the prior year when excluding restructuring and related costs, acquisition and integration costs, and a litigation matter. The year-over-year increase was primarily driven by increased SG&A from the APS business of $11.8 million, increased investment in digital transformation and increased legal and recycling fees. This increase was partially offset by Project Momentum savings of approximately $14 million in the period.(1) Advertising and Promotion Expense (A&P) A&P was 4.1% of Net sales for the fourth fiscal quarter and 5.1% of Net sales for fiscal 2025. A&P spending in the prior year was 4.6% for the fourth fiscal quarter of 2024 and 5.0% for fiscal 2024. For the quarter, this was a decrease of 50 basis points, or $3.3 million and for fiscal 2025 this was an increase of 10 basis points or $8.0 million. Earnings Per Share and Adjusted EBITDA Fourth Quarter Full Fiscal Year (In millions, except per share data) 2025 2024 2025 2024 Net earnings $ 34.9 $ 47.6 $ 239.0 $ 38.1 Diluted net earnings per common share $ 0.50 $ 0.65 $ 3.32 $ 0.52 Adjusted net earnings(1) $ 72.8 $ 89.3 $ 253.1 $ 241.3 Adjusted diluted net earnings per common share(1) $ 1.05 $ 1.22 $ 3.52 $ 3.32 Adjusted EBITDA(1) $ 171.2 $ 187.3 $ 623.6 $ 612.4 Currency neutral Adjusted diluted net earnings per common share(1) $ 1.08 $ 3.59 Currency neutral Adjusted EBITDA(1) $ 173.3 $ 629.4 The decline in net earnings in the fourth fiscal quarter was primarily driven by a current year non-cash pre-tax impairment charge of $5.9 million on certain proprietary formulas the Company no longer plans to utilize and the increase in the loss on extinguishment of debt. The increase in net earnings in fiscal 2025 was primarily driven by the current and prior year production credits of $120.9 million recorded in fiscal 2025. Fiscal 2024 was further impacted by the non-cash pre-tax impairment charge of $110.6 million. For the fourth fiscal quarter, the decrease in Adjusted earnings and Adjusted EBITDA reflects the decrease in Gross margin due to the increased product costs and tariffs, as well as increased SG&A spending and unfavorable currency impacts, partially offset by Project Momentum savings, FY25 production tax credits and lower A&P spending. Adjusted earnings per share was further impacted by higher interest expense as the Company's overall debt balance has increased, partially offset by decreased tax expense. For the full year, Adjusted net earnings per share and Adjusted EBITDA reflects improvement driven by Project Momentum, as well as the FY25 production credits, which were more than enough to offset the impacts of lower consumer demand and increased costs. Adjusted earnings per share further benefited from lower tax expense. For the quarter, currency had an unfavorable pre-tax impact of $2.3 million, or $0.03 per share, and for fiscal 2025, currency had an unfavorable pre-tax impact of $6.0 million, or $0.07 per share. Capital Allocation Operating cash flow for fiscal 2025 was $147.1 million. Fiscal 2025 free cash flow was $63.2 million, or 2.1% of Net sales. The Company repurchased 1.2 million shares of common stock for $27.1 million, or $22.49 per share during the fourth fiscal quarter. During fiscal 2025, the Company repurchased a total of 4.0 million shares of common stock at $22.42 per share. The Company paid dividends in the quarter of $21.3 million, or $0.30 per common share. Dividend payments for fiscal 2025 were $87.1 million, or $1.20 per common share. The Company refinanced $500.0 million of existing debt during the fourth quarter. The proceeds were used to redeem the 2027 6.50% notes and fully restore revolver capacity. Subsequent to year-end, the Company received a tax refund of $50.7 million, which included the fiscal 2024 production credit refund. The Company utilized these funds, as well as other funds, to pay down approximately $80.0 million of outstanding debt. Financial Outlook and Assumptions for Fiscal 2026 (1) For fiscal 2026, we expect organic Net sales to be flat to slightly up in both Batteries and Lights and Auto Care. Gross margin is expected to modestly decline, as the impact of tariffs will be largely offset through already executed pricing, production credits and productivity initiatives, with slight margin dilution from the inclusion of the APS business for the full year. As a result, we expect to deliver adjusted earnings per share for the full year in the range of $3.30 to $3.60 and Adjusted EBITDA in the range of $580 million to $610 million. Our earnings cadence this year will be influenced by a challenging sales comparison and transitory costs, both of which are primarily impacting the first quarter. Following the first quarter, we expect to generate double digit Adjusted earnings per share growth over the remainder of the year. For the first quarter, we expect organic Net sales to decline high-single digits and Adjusted earnings per share to be in the range of $0.20 to $0.30. Webcast Information In conjunction with this announcement, the Company posted prepared comments under the Investor/Events & Presentation section of the Company website and will hold an investor conference call beginning at 10:00 a.m. eastern time today. The call will focus on fourth quarter and fiscal 2025 financial results and the financial outlook for fiscal 2026. All interested parties may access a live webcast of this conference call at www.energizerholdings.com, under "Investors" and "Events and Presentations" tabs or by using the following link: https://app.webinar.net/weKgmMqmP4p For those unable to participate during the live webcast, a replay will be available on www.energizerholdings.com, under "Investors," "Events and Presentations," and "Past Events" tabs. (1) See Press Release attachments and supplemental schedules for additional information, including the GAAP to Non-GAAP reconciliations. This document contains both historical and forward-looking statements. Forward-looking statements are not based on historical facts but instead reflect our expectations, estimates or projections concerning future results or events, including, without limitation, the future sales, gross margins, costs, earnings, cash flows, tax rates and performance of the Company. These statements generally can be identified by the use of forward-looking words or phrases such as "believe," "expect," "expectation," "anticipate," "may," "could," "will," "intend," "belief," "estimate," "plan," "target," "predict," "likely," "should," "forecast," "outlook," or other similar words or phrases. These statements are not guarantees of performance and are inherently subject to known and unknown risks, uncertainties and assumptions that are difficult to predict and could cause our actual results to differ materially from those indicated by those statements. We cannot assure you that any of our expectations, estimates or projections will be achieved. The forward-looking statements included in this document are only made as of the date of this document and we disclaim any obligation to publicly update any forward-looking statement to reflect subsequent events or circumstances. All forward-looking statements should be evaluated with the understanding of their inherent uncertainty. Numerous factors could cause our actual results and events to differ materially from those expressed or implied by forward-looking statements, including, without limitation: Global economic and financial market conditions beyond our control might materially and negatively impact us. Competition in our product categories might hinder our ability to execute our business strategy, achieve profitability, or maintain relationships with existing customers. Changes in the retail environment and consumer preferences could adversely affect our business, financial condition and results of operations. We must successfully manage the demand, supply, and operational challenges brought on by any disease outbreak, including epidemics, pandemics, or similar widespread public health concerns. Loss or impairment of the reputation of our Company or our leading brands or failure of our marketing plans could have an adverse effect on our business. Loss of any of our principal customers could significantly decrease our sales and profitability. Our ability to meet our growth targets depends on successful product, marketing and operations innovation and successful responses to competitive innovation and changing consumer habits. We are subject to risks related to our international operations, including tariffs and currency fluctuations, which could adversely affect our results of operations. If we fail to protect our intellectual property rights, competitors may manufacture and market similar products, which could adversely affect our market share and results of operations. Changes in production costs, including raw material prices and transportation costs, from inflation or otherwise, have adversely affected, and in the future could erode, our profit margins and negatively impact operating results. Our reliance on certain significant suppliers subjects us to numerous risks, including possible interruptions in supply, which could adversely affect our business. Our business is vulnerable to the availability of raw materials, our ability to forecast customer demand and our ability to manage production capacity. The manufacturing facilities, supply channels or other business operations of the Company and our suppliers may be subject to disruption from events beyond our control. The Company's future results may be affected by its operational execution, including its ability to achieve cost savings as a result of any current or future restructuring events. If our goodwill and indefinite-lived intangible assets become impaired, we will be required to record impairment charges, which may be significant. A failure of a key information technology system could adversely impact our ability to conduct business. We rely significantly on information technology and any inadequacy, interruption, theft or loss of data, malicious attack, integration failure, failure to maintain the security, confidentiality or privacy of sensitive data residing on our systems or other security failure of that technology could harm our ability to effectively operate our business and damage the reputation of our brands. We may not be able to attract, retain and develop key employees, as well as effectively manage human capital resources. We have significant debt obligations that could adversely affect our business. Our credit ratings are important to our cost of capital. We may experience losses or be subject to increased funding and expenses related to our pension plans. The estimates and assumptions on which our financial projections are based may prove to be inaccurate, which may cause our actual results to materially differ from our projections, which may adversely affect our future profitability, cash flows and stock price. If we pursue strategic acquisitions, divestitures or joint ventures, we might experience operating difficulties, dilution, and other consequences that may harm our business, financial condition, and operating results, and we may not be able to successfully consummate favorable transactions or successfully integrate acquired businesses. Our business involves the potential for product liability claims, labeling claims, commercial claims and other legal claims against us, which could affect our results of operations and financial condition and result in product recalls or withdrawals. Our business is subject to increasing government regulations in both the U.S. and abroad that could impose material costs. Increased focus by governmental and non-governmental organizations, customers, consumers and shareholders on environmental, social and governance (ESG) issues, including those related to sustainability and climate change, may have an adverse effect on our business, financial condition and results of operations and damage our reputation. We are subject to environmental laws and regulations that may expose us to significant liabilities and have a material adverse effect on our results of operations and financial condition. Section 45X of the Internal Revenue Code contains production tax credits for certain battery components. Our ability to benefit from Section 45X production tax credits is not guaranteed and is dependent upon the federal government's ongoing implementation, guidance, regulations, or rulemakings. In addition, other risks and uncertainties not presently known to us or that we consider immaterial could affect the accuracy of any such forward-looking statements. The list of factors above is illustrative, but by no means exhaustive. All forward-looking statements should be evaluated with the understanding of their inherent uncertainty. Additional risks and uncertainties include those detailed from time to time in our publicly filed documents, including those described under the heading "Risk Factors" in our Form 10-K filed with the Securities and Exchange Commission on November 19, 2024 and in our Form 10-Q filed August 4, 2025. ENERGIZER HOLDINGS, INC. CONSOLIDATED STATEMENTS OF EARNINGS (Condensed) (In millions, except per share data - Unaudited) Quarter Ended September 30, Twelve Months Ended September 30, 2025 2024 2025 2024 Net sales $ 832.8 $ 805.7 $ 2,952.7 $ 2,887.0 Cost of products sold (1) 528.4 498.9 1,720.0 1,782.7 Gross profit 304.4 306.8 1,232.7 1,104.3 Selling, general and administrative expense (1) 136.8 146.1 532.4 526.3 Advertising and promotion expense 34.1 37.4 151.7 143.7 Research and development expense 8.3 8.5 32.6 31.6 Amortization of intangible assets 14.6 14.7 58.7 58.2 Impairment of intangible assets (2) 5.9 — 5.9 110.6 Interest expense 40.3 37.8 154.3 155.7 Loss on extinguishment/modification of debt (3) 6.8 0.3 12.1 2.4 Other items, net (1) (4) 4.2 2.5 0.9 22.0 Earnings before income taxes 53.4 59.5 284.1 53.8 Income tax expense 18.5 11.9 45.1 15.7 Net earnings $ 34.9 $ 47.6 $ 239.0 $ 38.1 Basic net earnings per common share $ 0.51 $ 0.66 $ 3.37 $ 0.53 Diluted net earnings per common share $ 0.50 $ 0.65 $ 3.32 $ 0.52 Weighted average shares of common stock - Basic 68.4 71.8 70.9 71.8 Weighted average shares of common stock - Diluted 69.5 73.0 72.0 72.7 (1) See the attached Supplemental Schedules - Non-GAAP Reconciliations, which break out the Project Momentum restructuring and related costs, Network transition costs, FY23 & FY24 production tax credits, Acquisition and integration related costs, and Litigation matters recorded included within these lines. (2) The non-cash impairment of intangible assets for the quarter and twelve months ended September 30, 2025 related to impairing the remaining book value of certain proprietary formulas the Company plans to no longer utilize. The non-cash Impairment of intangible assets for the twelve months ended September 30, 2024 related to the Company's Rayovac trade name impairment of $85.2 million and Varta trade name impairment of $25.4 million. (3) The Loss on extinguishment/modification of debt for the quarter ended September 30, 2025 related to the Company's September 2025 redemption of the $300.0 million Senior Notes due in 2027. The loss for the twelve months ended September 30, 2025 also included the refinancing and extension of the Company's $760 million term loan and $500 million credit facility completed earlier in the year. The Loss on extinguishment/modification of debt for the quarter and twelve months ended September 30, 2024 related to the early repayment of term loan during the respective periods, as well as the term loan repricing during the prior year. (4) During December 2023, a new president was inaugurated in Argentina bringing significant economic reform to the country including devaluing the Argentine Peso by 50% in the month of December (the "December 2023 Argentina Economic Reform"). As a result of this reform and devaluation, the Company has recorded $22.0 million of currency exchange and related losses within Other items, net for the twelve months ended September 30, 2024. ENERGIZER HOLDINGS, INC. CONSOLIDATED BALANCE SHEETS (Condensed) (In millions - Unaudited) SEPTEMBER 30, 2025 2024 Assets Current assets Cash and cash equivalents $ 236.2 $ 216.9 Trade receivables 404.2 441.3 Inventories 781.2 657.3 Other current assets 257.5 163.4 Total current assets $ 1,679.1 $ 1,478.9 Property, plant and equipment, net 403.0 380.1 Operating lease assets 93.2 94.7 Goodwill 1,051.2 1,046.0 Other intangible assets, net 1,005.5 1,070.9 Deferred tax asset 166.6 145.8 Other assets 158.1 126.0 Total assets $ 4,556.7 $ 4,342.4 Liabilities and Shareholders' Equity Current liabilities Current maturities of long-term debt $ 8.6 $ 12.0 Current portion of finance leases 1.5 0.6 Notes payable 13.7 2.1 Accounts payable 402.2 433.1 Current operating lease liabilities 16.2 18.2 Other current liabilities 352.8 353.8 Total current liabilities $ 795.0 $ 819.8 Long-term debt 3,407.9 3,193.0 Operating lease liabilities 84.8 82.4 Deferred tax liability 6.1 8.3 Other liabilities 93.0 103.1 Total liabilities $ 4,386.8 $ 4,206.6 Shareholders' equity Common stock 0.8 0.8 Additional paid-in capital 603.5 667.6 Retained earnings/(losses) 87.0 (128.4) Treasury stock (295.8) (223.6) Accumulated other comprehensive loss (225.6) (180.6) Total shareholders' equity $ 169.9 $ 135.8 Total liabilities and shareholders' equity $ 4,556.7 $ 4,342.4 ENERGIZER HOLDINGS, INC. CONSOLIDATED STATEMENT OF CASH FLOWS (Condensed) (In millions - Unaudited) FOR THE YEARS ENDED SEPTEMBER 30, 2025 2024 Cash Flow from Operating Activities Net earnings $ 239.0 $ 38.1 Adjustments to reconcile net earnings to net cash flow from operations: Non-cash integration and restructuring charges 15.5 13.0 Impairment of intangible assets 5.9 110.6 Depreciation and amortization 126.7 120.5 Deferred income taxes (16.6) (43.3) Share-based compensation expense 25.6 23.1 Gain on sale of real estate — (4.4) Loss on extinguishment on debt 7.9 2.4 Foreign currency exchange loss included in income 1.6 32.1 Non-cash items included in income, net 11.9 17.8 Production tax credits (120.9) — Other, net (9.3) (2.2) Changes in assets and liabilities used in operations, net of acquisitions Decrease in accounts receivable, net 32.9 71.8 Increase in inventories (88.6) (4.0) Increase in other current assets (12.2) (0.1) (Decrease)/increase in accounts payable (60.0) 62.2 Decrease in other current liabilities (12.3) (8.0) Net cash from operating activities 147.1 429.6 Cash Flow from Investing Activities Capital expenditures (83.9) (97.9) Proceeds from sale of assets — 7.3 Acquisitions, net of cash acquired (14.3) (22.4) Purchase of available-for-sale securities — (5.2) Proceeds from sale of available-for-sale securities — 4.2 Net cash used by investing activities (98.2) (114.0) Cash Flow from Financing Activities Cash proceeds from issuance of debt with original maturities greater than 90 days 698.0 — Payments on debt with maturities greater than 90 days (523.5) (200.8) Net decrease in debt with maturities 90 days or less (0.1) (6.2) Debt issuance costs (13.6) (0.9) Premiums paid on extinguishment of debt (4.9) — Payment of acquisition indemnification hold back (0.5) — Dividends paid on common stock (87.1) (87.4) Common stock repurchased (89.7) — Taxes paid for withheld share-based payments (7.7) (5.0) Net cash used by financing activities (29.1) (300.3) Effect of exchange rate changes on cash, cash equivalents and restricted cash (0.5) (21.7) Net increase/(decrease) in cash, cash equivalents and restricted cash 19.3 (6.4) Cash, cash equivalents and restricted cash, beginning of period 216.9 223.3 Cash, cash equivalents and restricted cash, end of period $ 236.2 $ 216.9 ENERGIZER HOLDINGS, INC. Supplemental Schedules Introduction to the Reconciliation of GAAP and Non-GAAP Measures For the Quarter and Twelve Months ended September 30, 2025 The Company reports its financial results in accordance with accounting principles generally accepted in the U.S. ("GAAP"). However, management believes that certain non-GAAP financial measures provide users with additional meaningful comparisons to the corresponding historical or future period, and are used for management incentive compensation. These non-GAAP financial measures exclude items that are not reflective of the Company's on-going operating performance, such as restructuring and related costs, network transition costs, acquisition and integration costs, a litigation matter, FY23 & FY24 production credits, impairment of intangible assets, the loss on extinguishment/modification of debt, and the December 2023 Argentina Economic Reform. In addition, these measures help investors to analyze year over year comparability when excluding currency fluctuations as well as other Company initiatives that are not on-going. We believe these non-GAAP financial measures are an enhancement to assist investors in understanding our business and in performing analysis consistent with financial models developed by research analysts. Investors should consider non-GAAP measures in addition to, not as a substitute for, or superior to, the comparable GAAP measures. In addition, these non-GAAP measures may not be the same as similar measures used by other companies due to possible differences in methods and in the items being adjusted. We provide the following non-GAAP measures and calculations, as well as the corresponding reconciliation to the closest GAAP measure in the following supplemental schedules: Segment Profit. This amount represents the operations of our two reportable segments including allocations for shared support functions. General corporate and other expenses, amortization expense, impairment of intangible assets, interest expense, loss on extinguishment/modification of debt, other items, net, restructuring and related costs, network transition costs, FY23 & FY24 production credits, a litigation matter, and acquisition and integration costs have all been excluded from segment profit. Adjusted Net Earnings and Adjusted Diluted Net Earnings Per Common Share (EPS). These measures exclude the impact of restructuring and related costs, network transition costs, FY23 & FY24 production credits, impairment of intangible assets, costs related to acquisition and integration, a litigation matter, the loss on extinguishment/modification of debt, and the December 2023 Argentina Economic Reform. Non-GAAP Tax Rate. This is the tax rate when excluding the pre-tax impact of restructuring and related costs, network transition costs, impairment of intangible assets, costs related to acquisition and integration, FY23 & FY24 production credits, a litigation matter, the loss on extinguishment/modification of debt, and the December 2023 Argentina Economic Reform, as well as the related tax impact for these items, calculated utilizing the statutory rate for the jurisdiction where the impact was incurred. Organic. This is the non-GAAP financial measurement of the change in Net sales or segment profit that excludes or otherwise adjusts for the Acquisition impact, Change in highly inflationary markets and Impact of currency from the changes in foreign currency exchange rates as defined below: Acquisition impact. The Company completed the Advanced Power Solutions acquisition on May 2, 2025. These adjustments include the impact of the operations associated with the acquired branded battery business. The Company will be working to transition from these branded business to legacy brands by December 31, 2025. This does not include the impact of acquisition and integration costs associated with this acquisition. Change in highly inflationary markets. The Company is presenting separately all changes in sales and segment profit from our Egypt and Argentina affiliates due to the designation of the economies as highly inflationary as of October 1, 2024 and July 1, 2018, respectively. Impact of currency. The Company evaluates the operating performance of our Company on a currency neutral basis. The Impact of Currency is the change in foreign currency exchange rates year-over-year on reported results, which is calculated by comparing the value of current year foreign operations at the current period USD exchange rate versus the value of current year foreign operations at the prior period USD exchange rate. The impact of currency also includes (gains)/losses of currency hedging programs, and it excludes highly inflationary markets. Adjusted Comparisons. Detail for adjusted gross profit, adjusted gross margin, adjusted SG&A and adjusted SG&A as percent of sales and adjusted Other items, net are also supplemental non-GAAP measure disclosures. These measures exclude the impact of restructuring and related costs, network transition costs, acquisition and integration costs, FY23 & FY24 production credits, a litigation matter, and the December 2023 Argentina Economic Reform. EBITDA and Adjusted EBITDA. EBITDA is defined as net earnings before income tax provision, interest, the loss on extinguishment/modification of debt, and depreciation and amortization. Adjusted EBITDA further excludes the impact of the costs related to restructuring, network transition costs, FY23 & FY24 production credits, a litigation matter, and the December 2023 Argentina Economic Reform, impairment of intangible assets, acquisition and integration costs, and share based payments. Free Cash Flow. Free Cash Flow is defined as net cash provided by operating activities reduced by capital expenditures, net of the proceeds from asset sales. Net Debt. Net Debt is defined as total Company debt, less cash and cash equivalents. Currency-neutral. Currency-neutral excludes the Impact of currency as defined above on key measures. Highly inflationary markets are excluded from this calculation. Energizer Holdings, Inc. Supplemental Schedules - Segment Information and Supplemental Sales Data For the Quarter and Twelve Months ended September 30, 2025 (In millions, except per share data - Unaudited) Operations for Energizer are managed via two product segments: Batteries & Lights and Auto Care. Energizer's operating model includes a combination of standalone and shared business functions between the product segments, varying by country and region of the world. Shared functions include the sales and marketing functions, as well as human resources, IT and finance shared service costs. Energizer applies a fully allocated cost basis, in which shared business functions are allocated between segments. Such allocations are estimates, and may not represent the costs of such services if performed on a standalone basis. Segment sales and profitability, as well as the reconciliation to earnings before income taxes for the quarters and twelve months ended September 30, 2025 and 2024 are presented below: For the Quarter Ended September 30, For the Twelve Months Ended September 30, Net sales 2025 2024 2025 2024 Batteries & Lights $ 677.2 $ 651.6 $ 2,332.7 $ 2,259.5 Auto Care 155.6 154.1 620.0 627.5 Total Net sales $ 832.8 $ 805.7 $ 2,952.7 $ 2,887.0 Segment Profit Batteries & Lights $ 151.8 $ 179.5 $ 542.2 $ 554.8 Auto Care 25.8 20.0 105.6 94.1 Total segment profit $ 177.6 $ 199.5 $ 647.8 $ 648.9 General corporate and other expenses (1) (27.9) (28.7) (118.9) (115.3) Restructuring and related costs (2) (22.8) (27.1) (68.7) (91.7) Network transition costs (3) (2.1) (11.7) (19.7) (11.7) Acquisition and integration costs (2) (1.4) (2.3) (6.2) (7.2) FY23 & FY24 production credits (4) (0.5) — 78.0 — Amortization of intangible assets (14.6) (14.7) (58.7) (58.2) Impairment of intangible assets (5.9) — (5.9) (110.6) Litigation matter (5) — (13.7) 1.7 (13.7) Interest expense (40.3) (37.8) (154.3) (155.7) Loss on extinguishment/modification of debt (6.8) (0.3) (12.1) (2.4) December 2023 Argentina economic reform (2) — — — (22.0) Other items, net - Adjusted (6) (1.9) (3.7) 1.1 (6.6) Total earnings before income taxes $ 53.4 $ 59.5 $ 284.1 $ 53.8 (1) Recorded in SG&A on the Consolidated (Condensed) Statement of Earnings. (2) See the Supplemental Schedules - Non-GAAP Reconciliations for the line items where these charges are recorded in the Consolidated (Condensed) Statement of Earnings. (3) This represents incremental network transition costs, primarily related to freight and third-party packaging support, to maintain business continuity and service our customers as the Company decommissions certain facilities and relocates production and packaging lines as part of Project Momentum. These costs were recorded in Cost of products sold on the Consolidated (Condensed) Statement of Earnings. (4) During fiscal 2025, the Company obtained reasonable assurance on the qualification of certain battery cell and manufacturing component product credits (production credits) eligibility under Section 45X of the Internal Revenue Code. This adjustment represents the estimated production credits retroactive to the start of the credit period and prior to the current year. These credits were recorded in Cost of products sold on the Consolidated (Condensed) Statement of Earnings. (5) Litigation matter relates to a September 2024 Swiss court judgment against the Company which has now been resolved. (6) See the Supplemental Non-GAAP reconciliation for the Other items, net reconciliation between the reported and adjusted balances. Supplemental product information is presented below for depreciation and amortization: For the Quarter Ended September 30, For the Twelve Months Ended September 30, Depreciation and amortization 2025 2024 2025 2024 Batteries & Lights $ 14.3 $ 13.1 $ 54.9 $ 50.3 Auto Care 3.2 3.1 13.1 12.0 Total segment depreciation and amortization 17.5 16.2 68.0 62.3 Amortization of intangible assets 14.6 14.7 58.7 58.2 Total depreciation and amortization $ 32.1 $ 30.9 $ 126.7 $ 120.5 Energizer Holdings, Inc. Supplemental Schedules - GAAP EPS to Adjusted EPS Reconciliation For the Quarter and Twelve Months ended September 30, 2025 (In millions, except for per share data- Unaudited) The following tables provide a reconciliation of Net earnings and Diluted net earnings per common share to Adjusted net earnings and Adjusted diluted net earnings per share, which are non-GAAP measures. For the Quarter Ended September 30, For the Twelve Months Ended September 30, 2025 2024 2025 2024 Net earnings 34.9 47.6 239.0 38.1 Pre-tax adjustments Restructuring and related costs (1) $ 22.8 $ 27.1 $ 68.7 $ 91.7 Network transition costs (1) 2.1 11.7 19.7 11.7 Acquisition and integration (1) 1.4 2.3 6.2 7.2 FY23 & FY24 production credits (1) 0.5 — (78.0) — Impairment of intangible assets 5.9 — 5.9 110.6 Litigation matter (1) — 13.7 (1.7) 13.7 Loss on extinguishment/modification of debt 6.8 0.3 12.1 2.4 December 2023 Argentina Economic Reform (1) — — — 22.0 Total adjustments, pre-tax $ 39.5 $ 55.1 $ 32.9 $ 259.3 Total adjustments, after tax $ 37.9 $ 41.7 $ 14.1 $ 203.2 Adjusted net earnings (2) $ 72.8 $ 89.3 $ 253.1 $ 241.3 Diluted net earnings per common share $ 0.50 $ 0.65 $ 3.32 $ 0.52 Adjustments Restructuring and related costs $ 0.33 $ 0.28 $ 0.80 $ 0.97 Network transition costs 0.03 0.12 0.22 0.12 Acquisition and integration 0.03 0.02 0.08 0.08 FY23 & FY24 production credits 0.01 — (1.08) — Impairment of intangible assets 0.07 — 0.07 1.16 Litigation matter — 0.14 (0.02) 0.14 Loss on extinguishment/modification of debt 0.08 0.01 0.13 0.03 December 2023 Argentina Economic Reform — — — 0.30 Adjusted diluted net earnings per diluted common share $ 1.05 $ 1.22 $ 3.52 $ 3.32 Weighted average shares of common stock - Diluted 69.5 73.0 72.0 72.7 (1) See Supplemental Schedules - Non-GAAP Reconciliation for where these costs are recorded on the unaudited Consolidated (Condensed) Statement of Earnings. (2) The Effective tax rate for the Adjusted - Non-GAAP Net Earnings and Diluted EPS for the quarters ended September 30, 2025 and 2024 was 21.6% and 22.1%, respectively, and for the twelve months ended September 30, 2025 and 2024 was 20.2% and 22.9%, respectively, as calculated utilizing the statutory rate for the jurisdictions where the costs were incurred. Energizer Holdings, Inc. Supplemental Schedules - Currency Neutral Results For the Quarter and Twelve Months Ended September 30, 2025 (In millions, except per share data - Unaudited) For the Quarter Ended Prior Quarter Ended September 30, 2025 % Change % Change As Reported Impact of Currency(1) Currency Neutral September 30, 2024 As Reported Basis Currency Neutral Basis As Reported under GAAP Diluted net earnings per common share $ 0.50 $ (0.03) $ 0.53 $ 0.65 (23.1) % (18.5) % Net earnings $ 34.9 $ (1.8) $ 36.7 $ 47.6 (26.7) % (22.9) % As Adjusted (non-GAAP)(2) Adjusted diluted net earnings per common share $ 1.05 $ (0.03) $ 1.08 $ 1.22 (13.9) % (11.5) % Adjusted EBITDA $ 171.2 $ (2.3) $ 173.3 $ 187.3 (8.6) % (7.5) % For the Twelve Months Ended Prior Twelve Months Ended September 30, 2025 % Change % Change As Reported Impact of Currency(1) Currency Neutral September 30, 2024 As Reported Basis Currency Neutral Basis As Reported under GAAP Diluted net earnings per common share $ 3.32 $ (0.07) $ 3.39 $ 0.52 NM NM Net earnings $ 239.0 $ (4.8) $ 243.8 $ 38.1 NM NM As Adjusted (non-GAAP)(2) Adjusted diluted net earnings per common share $ 3.52 $ (0.07) $ 3.59 $ 3.32 6.0 % 8.1 % Adjusted EBITDA $ 623.6 $ (6.0) $ 629.4 $ 612.4 1.8 % 2.8 % (1) The Impact of Currency is the change in foreign currency exchange rates year-over-year on reported results, which is calculated by comparing the value of current year foreign operations at the current period USD exchange rate versus the value of current year foreign operations at the prior period USD exchange rate. The impact of currency also includes gains/(losses) of currency hedging programs, and it excludes highly inflationary markets. (2) See supplemental schedules - Non-GAAP Reconciliations for full reconciliations of the Company's non-GAAP adjusted amounts. NM - Percentages are not meaningful Energizer Holdings, Inc. Supplemental Schedules - Segment Sales For the Quarter and Twelve Months Ended September 30, 2025 (In millions, except per share data - Unaudited) Net sales Batteries & Lights Q1'25 % Chg Q2'25 % Chg Q3'25 % Chg Q4'25 % Chg FY '25 % Chg Net sales - prior year $ 617.8 $ 481.0 $ 509.1 $ 651.6 $ 2,259.5 Organic 24.9 4.0 % 14.2 3.0 % 2.5 0.5 % (18.2) (2.8) % 23.4 1.0 % Acquisition impact — — % — — % 20.8 4.1 % 42.8 6.6 % 63.6 2.8 % Change in highly inflationary markets (5.4) (0.9) % 1.2 0.2 % 1.4 0.3 % (2.8) (0.4) % (5.6) (0.2) % Impact of currency (4.9) (0.7) % (8.4) (1.7) % 1.3 0.2 % 3.8 0.5 % (8.2) (0.4) % Net sales - current year $ 632.4 2.4 % $ 488.0 1.5 % $ 535.1 5.1 % $ 677.2 3.9 % $ 2,332.7 3.2 % Auto Care Net sales - prior year $ 98.8 $ 182.3 $ 192.3 $ 154.1 $ 627.5 Organic 2.1 2.1 % (4.8) (2.6) % (1.7) (0.9) % 0.8 0.5 % (3.6) (0.6) % Change in highly inflationary markets 0.1 0.1 % 0.2 0.1 % — — % — — % 0.3 — % Impact of currency (1.7) (1.7) % (2.8) (1.6) % (0.4) (0.2) % 0.7 0.5 % (4.2) (0.6) % Net sales - current year $ 99.3 0.5 % $ 174.9 (4.1) % $ 190.2 (1.1) % $ 155.6 1.0 % $ 620.0 (1.2) % Total Net sales Net sales - prior year $ 716.6 $ 663.3 $ 701.4 $ 805.7 $ 2,887.0 Organic 27.0 3.8 % 9.4 1.4 % 0.8 0.1 % (17.4) (2.2) % 19.8 0.7 % Acquisition impact — — % — — % 20.8 3.0 % 42.8 5.3 % 63.6 2.2 % Change in highly inflationary markets (5.3) (0.7) % 1.4 0.2 % 1.4 0.2 % (2.8) (0.3) % (5.3) (0.2) % Impact of currency (6.6) (1.0) % (11.2) (1.7) % 0.9 0.1 % 4.5 0.6 % (12.4) (0.4) % Net sales - current year $ 731.7 2.1 % $ 662.9 (0.1) % $ 725.3 3.4 % $ 832.8 3.4 % $ 2,952.7 2.3 % Segment Profit Batteries & Lights Q1'25 % Chg Q2'25 % Chg Q3'25 % Chg Q4'25 % Chg FY '25 % Chg Segment Profit - prior year $ 132.4 $ 113.5 $ 129.4 $ 179.5 $ 554.8 Organic (6.5) (4.9) % (0.3) (0.3) % 27.7 21.4 % (26.9) (15.0) % (6.0) (1.1) % Acquisition impact — — % — — % 0.4 0.3 % 1.8 1.0 % 2.2 0.4 % Change in highly inflationary markets (3.5) (2.6) % 0.3 0.3 % 1.1 0.9 % (1.1) (0.6) % (3.2) (0.6) % Impact of currency (3.1) (2.4) % (1.2) (1.1) % 0.2 0.1 % (1.5) (0.8) % (5.6) (1.0) % Segment Profit - current year $ 119.3 (9.9) % $ 112.3 (1.1) % $ 158.8 22.7 % $ 151.8 (15.4) % $ 542.2 (2.3) % Auto Care Segment Profit - prior year $ 6.9 $ 40.4 $ 26.8 $ 20.0 $ 94.1 Organic 14.7 213.0 % (3.5) (8.7) % — — % 5.5 27.5 % 16.7 17.7 % Change in highly inflationary markets — — % 0.1 0.2 % — — % 0.1 0.5 % 0.2 0.2 % Impact of currency (1.1) (15.9) % (1.8) (4.4) % (2.7) (10.1) % 0.2 1.0 % (5.4) (5.7) % Segment Profit - current year $ 20.5 197.1 % $ 35.2 (12.9) % $ 24.1 (10.1) % $ 25.8 29.0 % $ 105.6 12.2 % Total Segment Profit Segment Profit - prior year $ 139.3 $ 153.9 $ 156.2 $ 199.5 $ 648.9 Organic 8.2 5.9 % (3.8) (2.5) % 27.7 17.7 % (21.4) (10.7) % 10.7 1.6 % Acquisition impact — — % — — % 0.4 0.3 % 1.8 0.9 % 2.2 0.3 % Change in highly inflationary markets (3.5) (2.5) % 0.4 0.3 % 1.1 0.7 % (1.0) (0.5) % (3.0) (0.5) % Impact of currency (4.2) (3.0) % (3.0) (2.0) % (2.5) (1.6) % (1.3) (0.7) % (11.0) (1.6) % Segment Profit - current year $ 139.8 0.4 % $ 147.5 (4.2) % $ 182.9 17.1 % $ 177.6 (11.0) % $ 647.8 (0.2) % Energizer Holdings, Inc. Supplemental Schedules - Non-GAAP Reconciliations For the Quarter and Twelve Months Ended September 30, 2025 (In millions, except per share data - Unaudited) Gross Profit Q1'25 Q2'25 Q3'25 Q4'25 Q1'24 Q2'24 Q3'24 Q4'24 2025 2024 Net sales $731.7 $662.9 $725.3 $832.8 $716.6 $663.3 $701.4 $805.7 $2,952.7 $2,887.0 Reported Cost of products sold 462.1 403.9 325.6 528.4 449.6 410.0 424.2 498.9 1,720.0 1,782.7 Gross profit $269.6 $259.0 $399.7 $304.4 $267.0 $253.3 $277.2 $306.8 $1,232.7 $1,104.3 Gross margin 36.8 % 39.1 % 55.1 % 36.6 % 37.3 % 38.2 % 39.5 % 38.1 % 41.7 % 38.3 % Adjustments Restructuring and related costs 9.4 8.7 2.9 12.8 12.8 15.5 13.4 21.2 33.8 62.9 Network transition costs 14.0 2.7 0.9 2.1 — — — 11.7 19.7 11.7 Acquisition and integration costs — — — 0.5 2.9 — 0.2 — 0.5 3.1 FY23 & FY24 Production credits — — (78.5) 0.5 — — — — (78.0) — Cost of products sold - adjusted 438.7 392.5 400.3 512.5 433.9 394.5 410.6 466.0 $1,744.0 1,705.0 Adjusted Gross profit $293.0 $270.4 $325.0 $320.3 $282.7 $268.8 $290.8 $339.7 $1,208.7 $1,182.0 Adjusted Gross margin 40.0 % 40.8 % 44.8 % 38.5 % 39.5 % 40.5 % 41.5 % 42.2 % 40.9 % 40.9 % SG&A Q1'25 Q2'25 Q3'25 Q4'25 Q1'24 Q2'24 Q3'24 Q4'24 2025 2024 Reported SG&A $131.3 $136.0 $128.3 $136.8 $128.1 $122.5 $129.6 $146.1 $532.4 $526.3 Reported SG&A % of Net sales 17.9 % 20.5 % 17.7 % 16.4 % 17.9 % 18.5 % 18.5 % 18.1 % 18.0 % 18.2 % Adjustments Restructuring and related costs 10.9 9.2 5.1 7.7 9.6 7.9 9.8 7.1 32.9 34.4 Acquisition and integration costs 1.2 2.3 1.3 0.9 0.7 0.7 1.4 2.3 5.7 5.1 Litigation matter — — (1.7) — — — — 13.7 (1.7) 13.7 SG&A Adjusted - subtotal $119.2 $124.5 $123.6 $128.2 $117.8 $113.9 $118.4 $123.0 $495.5 $473.1 SG&A Adjusted % of Net sales 16.3 % 18.8 % 17.0 % 15.4 % 16.4 % 17.2 % 16.9 % 15.3 % 16.8 % 16.4 % Other items, net Q1'25 Q2'25 Q3'25 Q4'25 Q1'24 Q2'24 Q3'24 Q4'24 2025 2024 Interest income $(1.2) $(0.6) $(0.2) $(1.2) $(5.6) $(2.4) $(1.4) $(1.3) $(3.2) $(10.7) Foreign currency exchange (loss)/gain (3.8) 0.4 2.0 3.2 2.7 5.9 (0.3) 2.8 1.8 11.1 Pension benefit other than service costs — — — 0.1 1.0 1.0 1.1 0.9 0.1 4.0 Other — 0.3 0.1 (0.2) 0.9 — — 1.3 0.2 2.2 Other items, net - Adjusted $(5.0) $0.1 $1.9 $1.9 $(1.0) $4.5 $(0.6) $3.7 $(1.1) $6.6 Acquisition and integration - TSA income — — — — (1.0) — — — — (1.0) December 2023 Argentina Economic Reform — — — — 21.0 1.0 — — — 22.0 Gain on sale of real estate (restructuring) — — — — — — (3.7) (0.7) — (4.4) Restructuring and related costs — (0.3) — 2.3 — — (0.7) (0.5) 2.0 (1.2) Total Other items, net $(5.0) $(0.2) $1.9 $4.2 $19.0 $5.5 $(5.0) $2.5 $0.9 $22.0 Restructuring and related costs Q1'25 Q2'25 Q3'25 Q4'25 Q1'24 Q2'24 Q3'24 Q4'24 2025 2024 Cost of products sold - Restructuring costs $9.4 $8.7 $2.9 $7.6 $12.8 $15.5 $13.4 $21.2 $28.6 $62.9 Cost of products sold - US operating efficiency project — — — 5.2 — — — — $5.2 $— SG&A - Restructuring costs 4.8 3.8 3.4 5.2 5.7 4.6 7.0 2.6 17.2 19.9 SG&A - IT Enablement 6.1 5.4 1.7 2.5 3.9 3.3 2.8 4.5 15.7 14.5 Other items, net — (0.3) — 2.3 — — (4.4) (1.2) 2.0 (5.6) Total Restructuring and related costs $20.3 $17.6 $8.0 $22.8 $22.4 $23.4 $18.8 $27.1 $68.7 $91.7 Acquisition and integration Q1'25 Q2'25 Q3'25 Q4'25 Q1'24 Q2'24 Q3'24 Q4'24 2025 2024 Cost of products sold $— $— $— $0.5 $2.9 $— $0.2 $— $0.5 $3.1 SG&A 1.2 2.3 1.3 0.9 0.7 0.7 1.4 2.3 5.7 5.1 Other items, net — — — — (1.0) — — — — (1.0) Acquisition and integration related items $1.2 $2.3 $1.3 $1.4 $2.6 $0.7 $1.6 $2.3 $6.2 $7.2 Energizer Holdings, Inc. Supplemental Schedules - Non-GAAP Reconciliations For the Quarter and Twelve Months Ended September 30, 2025 (In millions, except per share data - Unaudited) Q1'25 Q2'25 Q3'25 Q4'25 FY 2025 Q4'24 FY2024 Net earnings $ 22.3 $ 28.3 $ 153.5 $ 34.9 $ 239.0 $ 47.6 $ 38.1 Income tax provision 7.8 8.1 10.7 18.5 45.1 11.9 15.7 Earnings before income taxes 30.1 36.4 164.2 53.4 284.1 59.5 53.8 Interest expense 37.0 38.0 39.0 40.3 154.3 37.8 155.7 Loss on extinguishment/modification of debt 0.1 5.2 — 6.8 12.1 0.3 2.4 Depreciation & Amortization 31.8 30.9 31.9 32.1 126.7 30.9 120.5 EBITDA 99.0 110.5 235.1 132.6 577.2 128.5 332.4 Adjustments: Restructuring and related costs 20.3 17.6 8.0 22.8 68.7 27.1 91.7 Network transitional costs 14.0 2.7 0.9 2.1 19.7 11.7 11.7 Acquisition and integration costs 1.2 2.3 1.3 1.4 6.2 2.3 7.2 FY23 & FY24 production credits — — (78.5) 0.5 (78.0) — — Litigation matter — — (1.7) — (1.7) 13.7 13.7 Impairment of intangible assets — — — 5.9 5.9 — 110.6 December 2023 Argentina Economic Reform — — — — — — 22.0 Share-based payments 6.2 7.2 6.3 5.9 25.6 4.0 23.1 Adjusted EBITDA $ 140.7 $ 140.3 $ 171.4 $ 171.2 $ 623.6 $ 187.3 $ 612.4 Twelve Months Ended September 30, Free cash flow 2025 2024 Net cash from operating activities $ 147.1 $ 429.6 Capital expenditures (83.9) (97.9) Proceeds from sale of assets — 7.3 Free cash flow $ 63.2 $ 339.0 Net Debt 9/30/2025 9/30/2024 Current maturities of long-term debt $ 8.6 $ 12.0 Current portion of finance leases 1.5 0.6 Notes payable 13.7 2.1 Long-term debt 3,407.9 3,193.0 Total debt per the balance sheet $ 3,431.7 $ 3,207.7 Cash and cash equivalents 236.2 216.9 Net Debt $ 3,195.5 $ 2,990.8 Energizer Holdings, Inc. Supplemental Schedules - Non-GAAP Reconciliations For the Quarter and Twelve Months Ended September 30, 2025 (In millions, except per share data - Unaudited) Fiscal 2026 Outlook Reconciliation - Adjusted earnings and Adjusted diluted net earnings per common share (EPS) Fiscal Q1 2026 Outlook Fiscal Year 2026 Outlook (in millions, except per share data) Net earnings EPS Net earnings EPS Fiscal 2026 - GAAP Outlook $(6) to $6 $(0.08) to $0.09 $172 to $207 $2.45 to $2.94 Impacts: Restructuring and related costs 15 12 0.21 0.17 49 42 0.70 0.60 Loss on extinguishment of debt 1 1 0.01 0.01 2 1 0.03 0.01 Acquisition and integration costs 4 2 0.06 0.03 8 4 0.12 0.05 Fiscal 2026 - Adjusted Outlook $14 to $21 $0.20 to $0.30 $231 to $254 $3.30 to $3.60 Fiscal 2026 Outlook Reconciliation - Adjusted EBITDA (in millions, except per share data) Net earnings $172 to $207 Income tax provision 16 to 57 Earnings before income taxes $188 to $264 Interest expense 155 145 Loss on extinguishment of debt 2 1 Amortization of intangible assets 55 50 Depreciation expense 75 65 EBITDA $475 to $525 Adjustments: Restructuring and related costs 65 55 Acquisition and integration costs 10 5 Share-based payments 30 25 Adjusted EBITDA $580 to $610 SOURCE Energizer Holdings, Inc. |
|||||
|
2025-11-18 11:53
5mo ago
|
2025-11-18 06:51
5mo ago
|
Vertiv and Caterpillar Announce Energy Optimization Collaboration to Expand End-to-End Power and Cooling Offerings for AI Data Centers | stocknewsapi |
CAT
VRT
|
|
|
New agreement aims to enhance data center efficiency, resiliency and deployment timelines through integrated energy solutions.
, /PRNewswire/ -- Vertiv (NYSE: VRT), a global leader in critical digital infrastructure, and Caterpillar Inc. (NYSE: CAT), a global leader in power systems, today announced the signing of a strategic undertaking to collaborate on advanced energy optimization solutions for data centers. This initiative will integrate Vertiv's power distribution and cooling portfolio with Caterpillar's, and its subsidiary Solar Turbines', product and expertise in power generation and CCHP (Combined Cooling, Heat and Power) to deliver pre-designed architectures that simplify deployment, accelerate time-to-power and optimize performance for data center operations. Vertiv and Caterpillar announce a collaboration to enhance data center efficiency, resiliency and deployment timelines through integrated energy solutions. A Powerful Collaboration: This collaboration directly addresses the growing demand for on-site energy solutions that deliver reliable power and cooling. Together, the companies are able to offer a fully integrated solution with validated interfaces and performance, enabling customers to accelerate design, installation and deployment. Caterpillar and Solar Turbines will supply power generation solutions, such as natural gas turbines and reciprocating engines, to deliver dependable, scalable electric power and thermal energy for CCHP. Vertiv will provide a complete portfolio of power and cooling solutions and services, packaged as modular, pre-designed blocks, to shorten design cycles and standardize deployment. The Customer Advantages: Accelerates Time-to-Power - by utilizing predesigned, modular reference architectures to speed up deployment time. Lowers PUE (Power Usage Effectiveness) – enables improved energy efficiency and carbon footprint because the system is optimized end-to-end: power, cooling, distribution and dynamic load management, compared to traditional design. Global lifecycle support - the offering is backed by the trusted, global service and support networks of both Vertiv and Caterpillar. "This collaboration with Caterpillar and Solar Turbines is a cornerstone of our Bring Your Own Power & Cooling (BYOP&C) strategy and aligns seamlessly with our grid-to-chip framework by offering resilient, on-site power generation solutions. This is optimal for customers looking to reduce or eliminate grid dependence," said Gio Albertazzi, CEO, at Vertiv. "By combining our complementary technologies, portfolios and expertise, we are enabling coordinated integration. Our pre-engineered, interoperability-tested building blocks let customers execute design, build and deploy concurrently, with predictable system performance." "As AI-driven workloads continue to accelerate, the demand for robust and scalable power infrastructure and cooling is becoming increasingly critical," said Jason Kaiser, group president of Caterpillar Power & Energy. "Our collaboration with Vertiv will enable us to deliver integrated, on-site energy solutions that lower PUE and meet customers' evolving needs." This initiative directly addresses the growing demand for on-site energy solutions and offers a coordinated, customer-first approach to solution design and implementation. The Vertiv and Caterpillar Memorandum of Understanding (MOU) represents a pivotal step in further refining this ecosystem, enabling customers to overcome energy constraints and deploy optimized AI centers. To learn more about Vertiv's end-to-end power and thermal management solutions, visit Vertiv.com. To learn more about the Caterpillar capability, visit Caterpillar.com / SolarTurbines.com. About Vertiv Vertiv (NYSE: VRT) brings together hardware, software, analytics and ongoing services to enable its customers' vital applications to run continuously, perform optimally and grow with their business needs. Vertiv solves the most important challenges facing today's data centers, communication networks and commercial and industrial facilities with a portfolio of power, cooling and IT infrastructure solutions and services that extends from the cloud to the edge of the network. Headquartered in Westerville, Ohio, USA, Vertiv does business in more than 130 countries. For more information, and for the latest news and content from Vertiv, visit Vertiv.com. About Caterpillar With 2024 sales and revenues of $64.8 billion, Caterpillar Inc. is the world's leading manufacturer of construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines and diesel-electric locomotives. For 100 years, we've been helping customers build a better, more sustainable world and are committed and contributing to a reduced-carbon future. Our innovative products and services, backed by our global dealer network, provide exceptional value that helps customers succeed. Caterpillar does business on every continent, principally operating through three primary segments – Construction Industries, Resource Industries and Energy & Transportation – and providing financing and related services through our Financial Products segment. Visit us at caterpillar.com or join the conversation on our social media channels. About Solar Turbines Solar Turbines Incorporated, headquartered in San Diego, is a wholly owned subsidiary of Caterpillar Inc. Solar manufactures the world's most widely used family of mid-sized industrial gas turbines from the 1 – 39 MW range. More than 15,000 Solar units are operating in 100 countries around the world. Primary applications include electric power generation, oil and natural gas production and natural gas transmission. Forward-looking statements This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27 of the Securities Act, and Section 21E of the Securities Exchange Act. These statements are only a prediction. Actual events or results may differ materially from those in the forward-looking statements set forth herein. Readers are referred to Vertiv's filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q for a discussion of these and other important risk factors concerning Vertiv and its operations. Vertiv is under no obligation to, and expressly disclaims any obligation to, update or alter its forward-looking statements, whether as a result of new information, future events or otherwise. VERTIV CONTACT [email protected] CATERPILLAR CONTACT [email protected] SOURCE Vertiv Holdings Co |
|||||
|
2025-11-18 11:53
5mo ago
|
2025-11-18 06:51
5mo ago
|
Transocean Ltd. Announces Exercised Options Totaling $89 Million | stocknewsapi |
RIG
|
|
|
STEINHAUSEN, Switzerland, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Transocean Ltd. (NYSE: RIG) today announced contract fixtures for one ultra-deepwater drillship and two harsh environment semisubmersibles. In aggregate, the fixtures represent approximately $89 million in firm contract backlog.
In Brazil, Petrobras exercised a 90-day option for the Deepwater Mykonos in direct continuation of its current program. The program is expected to contribute approximately $33 million in backlog. In Norway, a two-well option was exercised for the Transocean Enabler at a dayrate of $453,000 per day, excluding additional services. In Romania, OMV Petrom exercised a one-well option for the Transocean Barents at a dayrate of $480,000 per day. About Transocean Transocean is a leading international provider of offshore contract drilling services for oil and gas wells. The company specializes in technically demanding sectors of the global offshore drilling business with a particular focus on ultra-deepwater and harsh environment drilling services and operates the highest specification floating offshore drilling fleet in the world. Transocean owns or has partial ownership interests in and operates a fleet of 27 mobile offshore drilling units, consisting of 20 ultra-deepwater floaters and seven harsh environment floaters. Forward-Looking Statements The statements described herein that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements could contain words such as “possible,” “intend,” “will,” “if,” “expect,” or other similar expressions. Forward-looking statements are based on management’s current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are beyond Transocean’s control, and in many cases, cannot be predicted. As a result, actual results could differ materially from those indicated by these forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, risks relating to the terms and timing of the Tender Offer, including the acceptance for purchase of any Notes validly tendered and the expected expiration time and the satisfaction or waiver of certain conditions of the Tender Offer, risks relating to the closing of the New Notes Offering, including the terms and timing thereof and the satisfaction of customary closing conditions, conditions in financial markets, investor response to the New Notes Offering and the Tender Offer, and other factors, including those risks discussed in the section entitled “Risk Factors” in Transocean’s most recent Annual Report on Form 10-K for the year ended December 31, 2024, and in Transocean’s other filings with the United States Securities and Exchange Commission (the “SEC”), which are available free of charge on the SEC’s website at: www.sec.gov. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated. All subsequent written and oral forward-looking statements attributable to Transocean, the Company or to persons acting on their behalf are expressly qualified in their entirety by reference to these risks and uncertainties. You should not place undue reliance on forward-looking statements. Each forward-looking statement speaks only as of the date of the particular statement. Transocean expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statement to reflect any change in its expectations or beliefs with regard to the statement or any change in events, conditions or circumstances on which any forward-looking statement is based, except as required by law. Analyst Contact: Alison Johnson +1 713-232-7214 Media Contact: Kristina Mays +1 713-232-7734 |
|||||
|
2025-11-18 11:53
5mo ago
|
2025-11-18 06:51
5mo ago
|
Timken to Participate in Upcoming Investor Conferences | stocknewsapi |
TKR
|
|
|
Resources
Investor Relations Journalists Agencies Client Login Send a Release News Products Contact , /PRNewswire/ -- The Timken Company (NYSE: TKR; www.timken.com), a global technology leader in engineered bearings and industrial motion, will participate in two upcoming investor conferences in New York City. Neil Frohnapple, vice president of investor relations, will take part in the Goldman Sachs Industrials Conference on Wednesday, Dec. 3, 2025. Michael A. Discenza, vice president and chief financial officer and Frohnapple will participate in the Melius Investor Conference on Wednesday, Dec. 10, 2025. Materials shared with investors during the conferences will be available online at investors.timken.com. About The Timken Company The Timken Company (NYSE: TKR; www.timken.com), a global technology leader in engineered bearings and industrial motion, designs a growing portfolio of next-generation products for diverse industries. For more than 125 years, Timken has used its specialized expertise to innovate and create customer-centric solutions that increase reliability and efficiency. Timken posted $4.6 billion in sales in 2024 and employs approximately 19,000 people globally, operating from 45 countries. Media Relations: Scott Schroeder 234.262.6420 [email protected] Investor Relations: Neil Frohnapple 234.262.2310 [email protected] SOURCE The Timken Company Also from this source |
|||||
|
2025-11-18 10:47
5mo ago
|
2025-11-18 05:00
5mo ago
|
Gilead Joins Partners for Delivery of First Shipments of Breakthrough Twice-yearly Lenacapavir for HIV Prevention to Sub-Saharan Africa | stocknewsapi |
GILD
|
|
|
FOSTER CITY, Calif. & MBABANE, Eswatini--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the delivery of first shipments of lenacapavir – Gilead's twice-yearly injectable HIV-1 capsid inhibitor – for the prevention of HIV as pre-exposure prophylaxis (PrEP) to Eswatini and Zambia. The deliveries advance ongoing efforts to accelerate equitable access to long-acting HIV prevention options across sub-Saharan Africa, which is home to approximately two-thirds of all people livin.
|
|||||
|
2025-11-18 10:47
5mo ago
|
2025-11-18 05:00
5mo ago
|
Tencent Cloud and Ryde Strengthen Partnership with New Weixin/WeChat Mini Program Launch in Singapore to Enhance Visitors' Tourism and Mobility Experience | stocknewsapi |
RYDE
|
|
|
New Weixin/WeChat Mini Program set to enhance Chinese visitors' tourism and mobility experience in Singapore HONG KONG, HK / ACCESS Newswire / November 18, 2025 / Tencent Cloud, the cloud business of global technology company Tencent, today announced the expansion of its strategic partnership with Ryde Group Ltd(NYSE American:RYDE) ("Ryde" or the "Company"), a technology leader in mobility and quick commerce in Singapore. This new phase introduces the launch of the Weixin Mini Program in Singapore, building upon the earlier integration of Tencent Cloud Real-Time Communication (TRTC) technology that enhanced in-app communications within the Ryde platform.
|
|||||
|
2025-11-18 10:47
5mo ago
|
2025-11-18 05:00
5mo ago
|
Ethiopian Airlines selects RTX's Collins Aerospace for premium seating solutions across multiple fleets | stocknewsapi |
RTX
|
|
|
Africa's largest airline expands in-flight comfort with Collins' Elevation suites and Parallel Diamond business class seats
, /PRNewswire/ -- Collins Aerospace, an RTX (NYSE: RTX) business, signed an agreement with Ethiopian Airlines at the Dubai Air Show to provide premium lie-flat business class seating solutions across Ethiopian's number of fleet of Airbus A350 and Boeing 737 MAX aircraft. Ethiopian Airlines' 11 new A350-900 aircraft will feature Collins Elevation suites, offering premium privacy, comfort, and ample space to work, relax and dine. The agreement builds on the strong relationship between the African leading carrier, Ethiopian Airlines and Collins, which is also providing Elevation suites for the airline's recently announced 777-9 order. Together, the collaboration ensures a consistent and seamless passenger experience across both fleets. Fifty-six Ethiopian 737 MAX aircraft will be outfitted with Collins' Parallel Diamond business class seats, bringing elegant design and enhanced wide body comfort for longer range aircraft. "Collins' suite of premium business class solutions not only provide luxury air travel accommodations but are distinctly tailored to reflect and amplify Ethiopian's rapidly expanding brand to travelers across the globe," said Cynthia Muklevicz, vice president of Global Airlines & Lessors at Collins Aerospace. "Collins' focus on quality and function, aligned with Ethiopian's commitment to delivering world-class service and innovation, result in an elevated inflight experience that will delight passengers from Addis Ababa and throughout the world." Ethiopian Airlines Group Chief Operating Officer, Mr. Retta Melaku, on his part remarked, "As a customer-centric airline, we are thrilled to collaborate with Collins Aerospace and invest in products that would take our customers' comfort and overall flight experience to the next level. By combining Collins' technology such as the Elevation suites and Parallel Diamond seats with our onboard services, we are enhancing our passengers' in-flight experience with superior comfort, privacy, and truly reflecting the essence of Ethiopian hospitality and innovation." The reverse herringbone Elevation suite provides travelers exceptional living space, a privacy door and intuitively integrated stowage areas, perfect for storing and accessing personal items during flight. Thoughtful design and engineering provide increased in-suite living space for hips, knees and elbows, without impacting cabin densities. Collins' Parallel Diamond seat incorporates advanced kinematic design and is angled toward the windows to maximize passenger space, privacy and cabin density on a single-aisle aircraft. The seat features adjustment and transforms into a 78" lie-flat bed, serving as an ideal place to rest as narrow body aircraft continue to fly longer missions. About Collins Aerospace Collins Aerospace, an RTX business, is a leader in integrated and intelligent solutions for the global aerospace and defense industry. Our 80,000 employees are dedicated to delivering future-focused technologies to advance sustainable and connected aviation, passenger safety and comfort, mission success, space exploration, and more. About RTX RTX is the world's largest aerospace and defense company. With more than 185,000 global employees, we push the limits of technology and science to redefine how we connect and protect our world. Through industry-leading businesses – Collins Aerospace, Pratt & Whitney, and Raytheon – we are advancing aviation, engineering integrated defense systems for operational success, and developing next-generation technology solutions and manufacturing to help global customers address their most critical challenges. The company, with 2024 sales of more than $80 billion, is headquartered in Arlington, Virginia. For questions or to schedule an interview, please contact [email protected] About Ethiopian Ethiopian Airlines Group (Ethiopian) is a true African success story, transforming a visionary dream into a globally renowned reality for nearly eight decades. Operating flights to more than 160 domestic and international passengers, and cargo destinations across five continents, Ethiopian bridges the gaps between Africa and the world. Emphasizing passenger comfort and environmental sustainability, Ethiopian utilizes ultra-modern aircraft such as Boeing 737s, 777s, 787s, Airbus A350-900, A350-1000 and De Havilland Q400. Ethiopian, the Star Alliance member airline, champions in various coveted awards including Skytrax's 'Best Airline in Africa Award' for eight consecutive years, APEX 'Best Overall in Africa' award and 'Leadership in Connecting Africa through Transport' Award among others. Ethiopian aims to further excel in its success through a strategic plan dubbed 'Vision 2035' and become one of the top 20 most competitive and leading aviation groups in the world. Embracing a Pan-African spirit, Ethiopian is pursuing multi-hub strategy through hubs in Lomé, Togo with ASKY, in Lilongwe, Malawi with Malawi Airlines, in Lusaka, Zambia with Zambia Airways, and in Kinshasa, Democratic Republic of the Congo (DRC) with Air Congo. For more information, visit our website at www.ethiopianairlines.com email us at [email protected] , or call us at (251-11)517-8913/8165/8907. SOURCE RTX |
|||||
|
2025-11-18 10:47
5mo ago
|
2025-11-18 05:03
5mo ago
|
CommScope: From Debt Burden To Digital Revolution | stocknewsapi |
COMM
|
|
|
SummaryCommScope is well-positioned to benefit from surging demand for high-speed connectivity, digital infrastructure, and next-generation wireless technologies.COMM's strategic restructuring, including the $10B CCS asset sale, reduces debt and refocuses on high-growth broadband and enterprise wireless segments.Q3 2025 results exceeded expectations, with strong revenue and EBITDA growth, supporting management's optimistic outlook and upgraded full-year guidance.I rate COMM as a Buy, citing innovation, improved financials, and exposure to AI, data centers, and cloud growth, despite risks from customer concentration.J. Michael Jones/iStock Editorial via Getty Images
Investment thesis The modern world is undergoing revolutionary changes. The emerging era of big data creates a need not only for memory and computing power but also for faster internet, at home and at work. Everybody Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body. Recommended For You |
|||||
|
2025-11-18 10:47
5mo ago
|
2025-11-18 05:06
5mo ago
|
Robert Half: Macro Pressures, Competitive Questions | stocknewsapi |
RHI
|
|
|
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body. |
|||||
|
2025-11-18 10:47
5mo ago
|
2025-11-18 05:06
5mo ago
|
Roche oral drug shown to keep breast cancer at bay, boosting shares | stocknewsapi |
RHHBY
|
|
|
Roche's ROG.S experimental oral drug giredestrant has been shown to cut the risk of recurrence of a common form of breast cancer after surgery, boosting the company's shares and underpinning its traditional credentials in oncology.
|
|||||
|
2025-11-18 10:47
5mo ago
|
2025-11-18 05:07
5mo ago
|
Here's the message to draw from the S&P 500 falling below the 50-day average for the first time in 139 sessions | stocknewsapi |
IVV
SPLG
SPXL
SPY
SSO
UPRO
VOO
|
|
|
As the S&P 500 broke below the 50-day average for the first time in 139 sessions, MarketWatch looked back to find out what happened when the benchmark index broke below that technical level in the past.
|
|||||